0001445815 2026-01-01 2026-06-30 0001445815 2026-08-14 0001445815 2026-06-30 0001445815 2025-12-31 0001445815 us-gaap:RelatedPartyMember 2026-06-30 0001445815 us-gaap:RelatedPartyMember 2025-12-31 0001445815 us-gaap:NonrelatedPartyMember 2026-06-30 0001445815 us-gaap:NonrelatedPartyMember 2025-12-31 0001445815 2026-04-01 2026-06-30 0001445815 2025-04-01 2025-06-30 0001445815 2025-01-01 2025-06-30 0001445815 us-gaap:CommonStockMember 2024-12-31 0001445815 us-gaap:PreferredStockMember 2024-12-31 0001445815 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001445815 us-gaap:RetainedEarningsMember 2024-12-31 0001445815 2024-12-31 0001445815 us-gaap:CommonStockMember 2025-03-31 0001445815 us-gaap:PreferredStockMember 2025-03-31 0001445815 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001445815 us-gaap:RetainedEarningsMember 2025-03-31 0001445815 2025-03-31 0001445815 us-gaap:CommonStockMember 2025-12-31 0001445815 us-gaap:PreferredStockMember 2025-12-31 0001445815 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001445815 us-gaap:RetainedEarningsMember 2025-12-31 0001445815 us-gaap:CommonStockMember 2026-03-31 0001445815 us-gaap:PreferredStockMember 2026-03-31 0001445815 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001445815 us-gaap:RetainedEarningsMember 2026-03-31 0001445815 2026-03-31 0001445815 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001445815 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001445815 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001445815 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001445815 2025-01-01 2025-03-31 0001445815 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001445815 us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001445815 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001445815 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001445815 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001445815 us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001445815 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001445815 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001445815 2026-01-01 2026-03-31 0001445815 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001445815 us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001445815 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001445815 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001445815 us-gaap:CommonStockMember 2025-06-30 0001445815 us-gaap:PreferredStockMember 2025-06-30 0001445815 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001445815 us-gaap:RetainedEarningsMember 2025-06-30 0001445815 2025-06-30 0001445815 us-gaap:CommonStockMember 2026-06-30 0001445815 us-gaap:PreferredStockMember 2026-06-30 0001445815 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001445815 us-gaap:RetainedEarningsMember 2026-06-30 0001445815 srt:ParentCompanyMember 2017-10-05 0001445815 srt:ParentCompanyMember 2018-09-21 0001445815 BIXT:PharmalectinIncMember 2017-10-05 0001445815 BIXT:PharmalectinIncMember 2026-06-30 0001445815 BIXT:NDPDPharmaIncMember 2017-10-05 0001445815 BIXT:NDPDPharmaIncMember 2017-10-05 0001445815 BIXT:NDPDPharmaIncMember 2024-10-25 0001445815 BIXT:NDPDPharmaIncMember 2026-06-30 0001445815 BIXT:PharmalectinBVIMember 2022-03-17 0001445815 BIXT:PharmalectinIndiaPvtLtdMember 2022-08-30 0001445815 BIXT:PharmalectinIndiaPvtLtdMember 2022-08-30 2022-08-30 0001445815 BIXT:PromissoryNotesMember 2026-06-30 0001445815 BIXT:PromissoryNotesMember 2026-01-01 2026-06-30 0001445815 BIXT:TwoThousandTwentyOneNoteMember 2026-01-01 2026-06-30 0001445815 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001445815 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001445815 BIXT:DavidPlattMember us-gaap:ConvertiblePreferredStockMember 2026-01-30 2026-01-30 0001445815 BIXT:NDPDPharmaIncMember 2026-01-30 2026-01-30 0001445815 2025-01-01 2025-12-31 0001445815 BIXT:AffiliateMember 2026-06-30 0001445815 BIXT:AffiliateMember 2025-12-31 0001445815 srt:ChiefFinancialOfficerMember 2026-06-30 0001445815 srt:ChiefExecutiveOfficerMember 2025-12-31 0001445815 srt:ChiefFinancialOfficerMember 2026-01-01 2026-06-30 0001445815 srt:ChiefFinancialOfficerMember 2025-01-01 2025-12-31 0001445815 srt:DirectorMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001445815 srt:DirectorMember us-gaap:CommonStockMember 2025-01-01 2025-12-31 0001445815 srt:DirectorMember us-gaap:CommonStockMember 2025-10-01 2025-12-31 0001445815 srt:AffiliatedEntityMember 2026-06-30 0001445815 srt:AffiliatedEntityMember 2026-01-01 2026-06-30 0001445815 srt:AffiliatedEntityMember 2025-12-31 0001445815 srt:AffiliatedEntityMember 2025-01-01 2025-12-31 0001445815 BIXT:TwoThousandTwentyOneNotesMember us-gaap:ConvertibleNotesPayableMember BIXT:FourSecuritiesPurchaseAgreementsMember 2021-05-03 0001445815 BIXT:TwoThousandTwentyOneNotesMember us-gaap:ConvertibleNotesPayableMember BIXT:FourSecuritiesPurchaseAgreementsMember 2021-05-03 2021-05-03 0001445815 us-gaap:ConvertibleNotesPayableMember BIXT:ThreeNotesMember 2023-05-05 0001445815 us-gaap:ConvertibleNotesPayableMember BIXT:ThreeNotesMember 2023-05-05 2023-05-05 0001445815 us-gaap:ConvertibleNotesPayableMember BIXT:ThreeNotesMember 2024-07-15 0001445815 BIXT:TwoThousandTwentyOneNotesMember 2026-06-30 0001445815 BIXT:NoteSoldInExchangeForCashMember 2025-12-31 0001445815 BIXT:NoteSoldInExchangeForCashMember 2026-06-30 0001445815 2021-05-03 0001445815 2021-05-03 2021-05-03 0001445815 BIXT:MarketClosingOfCommonStockMember 2026-06-30 0001445815 srt:MinimumMember 2026-06-30 0001445815 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2026-05-08 0001445815 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2025-10-30 2026-05-08 0001445815 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2026-05-08 0001445815 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2025-10-30 2026-05-08 0001445815 us-gaap:PrivatePlacementMember 2026-05-08 0001445815 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2026-06-30 0001445815 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2026-06-30 0001445815 us-gaap:PrivatePlacementMember 2026-06-30 0001445815 us-gaap:PrivatePlacementMember 2026-01-01 2026-06-30 0001445815 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2026-07-01 0001445815 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2026-07-01 2026-07-01 0001445815 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2026-01-01 2026-06-30 0001445815 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2026-01-01 2026-06-30 0001445815 us-gaap:CommonStockMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2026-07-01 2026-07-01 0001445815 us-gaap:WarrantMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2026-07-01 2026-07-01 0001445815 us-gaap:MeasurementInputPriceVolatilityMember 2026-06-30 0001445815 us-gaap:MeasurementInputExpectedTermMember 2026-06-30 0001445815 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-06-30 0001445815 us-gaap:MeasurementInputExpectedDividendRateMember 2026-06-30 0001445815 us-gaap:WarrantMember 2025-12-31 0001445815 us-gaap:WarrantMember 2025-01-01 2025-12-31 0001445815 us-gaap:WarrantMember 2026-06-30 0001445815 BIXT:PreferredStockIssuedAndOutstandingMember 2025-01-01 2025-01-01 0001445815 BIXT:PreferredStockIssuedAndOutstandingMember 2025-01-01 0001445815 srt:AffiliatedEntityMember BIXT:StockConversionMember 2025-01-10 2025-01-10 0001445815 srt:AffiliatedEntityMember BIXT:StockConversionMember 2025-01-10 0001445815 srt:AffiliatedEntityMember BIXT:PayrollForfeitureMember 2025-03-31 2025-03-31 0001445815 srt:AffiliatedEntityMember BIXT:TwoThousandsTwentyOneStockPlanMember 2025-01-01 2025-06-30 0001445815 srt:AffiliatedEntityMember BIXT:TwoThousandsTwentyOneStockPlanMember 2025-06-30 0001445815 BIXT:PreferredStockIssuedAndOutstandingMember 2025-01-01 2025-06-30 0001445815 BIXT:PreferredStockIssuedAndOutstandingMember 2025-06-30 0001445815 BIXT:PreferredStockIssuedAndOutstandingMember 2026-01-01 2026-06-30 0001445815 BIXT:PreferredStockIssuedAndOutstandingMember 2026-06-30 0001445815 BIXT:CommonStockIssuedAndOutstandingMember 2025-01-01 2025-01-01 0001445815 BIXT:CommonStockIssuedAndOutstandingMember 2025-01-01 0001445815 BIXT:StockConversionMember 2025-01-10 2025-01-10 0001445815 BIXT:StockConversionMember 2025-01-10 0001445815 BIXT:StockPlanTwoThousandsTwentyOneMember 2025-01-01 2025-06-30 0001445815 BIXT:StockPlanTwoThousandsTwentyOneMember 2025-06-30 0001445815 BIXT:CommonStockIssuedAndOutstandingMember 2025-01-01 2025-06-30 0001445815 BIXT:CommonStockIssuedAndOutstandingMember 2025-06-30 0001445815 BIXT:CommonStockIssuedAndOutstandingMember 2026-01-01 2026-01-01 0001445815 BIXT:CommonStockIssuedAndOutstandingMember 2026-01-01 0001445815 us-gaap:PrivatePlacementMember 2026-01-23 2026-01-23 0001445815 us-gaap:PrivatePlacementMember 2026-01-23 0001445815 BIXT:WarrantsMember 2026-01-23 2026-01-23 0001445815 BIXT:WarrantsMember 2026-01-23 0001445815 BIXT:ConsultingFeesMember 2026-01-10 2026-01-10 0001445815 BIXT:ConsultingFeesMember 2026-01-10 0001445815 BIXT:ConsultingFeesMember 2026-02-10 2026-02-10 0001445815 BIXT:ConsultingFeesMember 2026-02-10 0001445815 BIXT:ConsultingFeesMember 2026-03-10 2026-03-10 0001445815 BIXT:ConsultingFeesMember 2026-03-10 0001445815 us-gaap:PrivatePlacementMember 2026-05-08 2026-05-08 0001445815 BIXT:WarrantsMember 2026-05-08 2026-05-08 0001445815 BIXT:WarrantsMember 2026-05-08 0001445815 BIXT:CommonStockIssuedAndOutstandingMember 2026-01-01 2026-06-30 0001445815 BIXT:CommonStockIssuedAndOutstandingMember 2026-06-30 0001445815 BIXT:CommonStockIssuedMember BIXT:ConsultingFeesMember 2026-01-01 2026-01-01 0001445815 BIXT:CommonStockIssuedMember BIXT:ConsultingFeesMember 2026-01-01 0001445815 BIXT:CommonStockIssuedMember BIXT:CommisionMember 2026-05-08 2026-05-08 0001445815 BIXT:CommonStockIssuedMember BIXT:CommisionMember 2026-05-08 0001445815 BIXT:CommonStockIssuedMember BIXT:ConsultingFeesMember 2026-06-30 2026-06-30 0001445815 BIXT:CommonStockIssuedMember BIXT:ConsultingFeesMember 2026-06-30 0001445815 BIXT:CommonStockIssuedMember 2026-06-30 2026-06-30 0001445815 BIXT:CommonStockIssuedMember 2026-06-30 0001445815 2026-01-23 0001445815 2026-01-23 2026-01-23 0001445815 us-gaap:WarrantMember 2026-01-23 2026-01-23 0001445815 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2026-01-23 2026-01-23 0001445815 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2026-01-23 0001445815 us-gaap:CommonStockMember 2026-01-23 0001445815 2026-05-08 0001445815 2026-05-08 2026-05-08 0001445815 us-gaap:WarrantMember 2026-05-08 2026-05-08 0001445815 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2026-05-08 2026-05-08 0001445815 us-gaap:CommonStockMember 2026-05-08 0001445815 srt:MinimumMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0001445815 srt:MaximumMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0001445815 srt:MinimumMember us-gaap:WarrantMember 2025-01-01 2025-06-30 0001445815 srt:MaximumMember us-gaap:WarrantMember 2025-01-01 2025-06-30 0001445815 us-gaap:WarrantMember 2025-01-01 2025-06-30 0001445815 BIXT:WarrantOneMember 2026-06-30 0001445815 BIXT:WarrantOneMember 2026-01-01 2026-06-30 0001445815 srt:MinimumMember BIXT:WarrantTwoMember 2026-06-30 0001445815 srt:MaximumMember BIXT:WarrantTwoMember 2026-06-30 0001445815 BIXT:WarrantTwoMember 2026-01-01 2026-06-30 0001445815 BIXT:WarrantTwoMember 2026-06-30 0001445815 BIXT:WarrantThreeMember 2026-06-30 0001445815 BIXT:WarrantThreeMember 2026-01-01 2026-06-30 0001445815 srt:MinimumMember us-gaap:WarrantMember 2026-06-30 0001445815 srt:MaximumMember us-gaap:WarrantMember 2026-06-30 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember 2021-01-15 2021-01-15 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember 2026-01-01 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember 2026-06-30 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember 2026-01-01 2026-06-30 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember 2025-06-30 0001445815 us-gaap:EmployeeStockOptionMember BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-01 2025-06-30 0001445815 srt:AffiliatedEntityMember 2025-01-01 2025-06-30 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-01 2025-01-01 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-01 0001445815 srt:AffiliatedEntityMember BIXT:StipendMember BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-06 2025-01-06 0001445815 srt:AffiliatedEntityMember BIXT:StipendMember BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-06 0001445815 BIXT:StipendMember BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-06 2025-01-06 0001445815 BIXT:StipendMember BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-06 0001445815 srt:AffiliatedEntityMember BIXT:BonusMember BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-06 2025-01-06 0001445815 srt:AffiliatedEntityMember BIXT:BonusMember BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-06 0001445815 BIXT:BonusMember BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-06 2025-01-06 0001445815 BIXT:BonusMember BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-06 0001445815 srt:AffiliatedEntityMember BIXT:StipendMember BIXT:TwoThousandTwentyOneStockPlanMember 2026-05-12 2026-05-12 0001445815 srt:AffiliatedEntityMember BIXT:StipendMember BIXT:TwoThousandTwentyOneStockPlanMember 2026-05-12 0001445815 BIXT:StipendMember BIXT:TwoThousandTwentyOneStockPlanMember 2026-05-12 2026-05-12 0001445815 BIXT:StipendMember BIXT:TwoThousandTwentyOneStockPlanMember 2026-05-12 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember 2025-01-01 2025-06-30 0001445815 srt:AffiliatedEntityMember BIXT:TwoThousandTwentyOneStockPlanMember BIXT:StipendMember 2026-01-01 2026-01-01 0001445815 srt:AffiliatedEntityMember BIXT:TwoThousandTwentyOneStockPlanMember BIXT:StipendMember 2026-01-01 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember BIXT:StipendMember 2026-01-01 2026-01-01 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember BIXT:StipendMember 2026-01-01 0001445815 srt:AffiliatedEntityMember BIXT:TwoThousandTwentyOneStockPlanMember BIXT:PerformanceGrantMember 2026-01-30 2026-01-30 0001445815 srt:AffiliatedEntityMember BIXT:TwoThousandTwentyOneStockPlanMember BIXT:PerformanceGrantMember 2026-01-30 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember BIXT:StipendMember 2026-03-31 2026-03-31 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember BIXT:StipendMember 2026-03-31 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember BIXT:StipendMember 2026-06-30 2026-06-30 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember BIXT:StipendMember 2026-06-30 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember 2026-01-01 2026-06-30 0001445815 BIXT:TwoThousandTwentyOneStockPlanMember 2026-06-30 0001445815 srt:DirectorMember us-gaap:PreferredStockMember 2026-06-30 0001445815 srt:DirectorMember us-gaap:PreferredStockMember 2026-01-01 2026-06-30 0001445815 BIXT:EmploymentAgreementsMember 2026-06-30 0001445815 2026-04-30 2026-04-30 0001445815 2026-04-30 0001445815 us-gaap:SubsequentEventMember 2026-07-01 2026-08-14 0001445815 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-08-14 0001445815 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2026-08-14 0001445815 us-gaap:SubsequentEventMember 2026-07-01 2026-07-01 0001445815 BIXT:UnitOfferingMember 2026-01-01 2026-06-30 0001445815 BIXT:Plan2021Member us-gaap:SubsequentEventMember 2026-07-01 2026-07-01 0001445815 BIXT:Plan2021Member us-gaap:SubsequentEventMember 2026-07-01 0001445815 BIXT:Plan2021OneMember us-gaap:SubsequentEventMember 2026-07-01 2026-07-01 0001445815 BIXT:Plan2021OneMember us-gaap:SubsequentEventMember 2026-07-01 0001445815 BIXT:ConsultingFeeMember us-gaap:SubsequentEventMember 2026-07-01 2026-07-01 0001445815 BIXT:ConsultingFeeMember us-gaap:SubsequentEventMember 2026-07-01 0001445815 BIXT:CommissionMember us-gaap:SubsequentEventMember 2026-07-01 2026-07-01 0001445815 BIXT:CommissionMember us-gaap:SubsequentEventMember 2026-07-01 0001445815 us-gaap:PrivatePlacementMember us-gaap:SubsequentEventMember 2026-07-08 2026-07-08 0001445815 us-gaap:PrivatePlacementMember us-gaap:SubsequentEventMember 2026-07-08 0001445815 BIXT:PrivatePlacementOneMember us-gaap:SubsequentEventMember 2026-07-08 2026-07-08 0001445815 BIXT:PrivatePlacementOneMember us-gaap:SubsequentEventMember 2026-07-08 0001445815 BIXT:ConsultingFeeOneMember us-gaap:SubsequentEventMember 2026-07-05 2026-07-05 0001445815 BIXT:ConsultingFeeOneMember us-gaap:SubsequentEventMember 2026-07-05 0001445815 BIXT:ConsultingFeeTwoMember us-gaap:SubsequentEventMember 2026-08-10 2026-08-10 0001445815 BIXT:ConsultingFeeTwoMember us-gaap:SubsequentEventMember 2026-08-10 0001445815 us-gaap:SubsequentEventMember 2026-08-14 2026-08-14 0001445815 us-gaap:SubsequentEventMember 2026-08-14 0001445815 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2026-07-08 2026-07-08 0001445815 us-gaap:WarrantMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2026-07-08 0001445815 us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2026-04-20 2026-05-08 0001445815 us-gaap:PrivatePlacementMember 2026-04-20 2026-05-08 0001445815 2026-04-20 2026-05-08 0001445815 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2026-04-20 2026-05-08 0001445815 us-gaap:CommonStockMember 2026-04-20 2026-05-08 iso4217:USD shares iso4217:USD shares pure iso4217:INR shares false Q2 --12-31 0001445815

10-Q true 2026-06-30 2026 false 001-35027 BIOXYTRAN, INC. NV 26-2797630 75 2nd Avenue Ste 605 Needham MA 02494 617 454-1199 Common Stock BIXT Yes Yes Non-accelerated Filer true false false 114695220

177384

509914

3551

177384

513465

156009

145087

333393

658552

1198685

824278

1076876

673317

58202

16272

1360606

82006

1360606

82006

355598

395668

50000

369730

403353

805000

5274697

3249894

5274697

3249894

0.001

50000000

43283991

43284

0.001

400000000

114695220

108147731

114695

108148

18633881

18301472

-23733164

-21044246

-4941304

-2591342

333393

658552

255479

102500

480958

452000

189121

94529

403095

248299

210000 27048 1703600 38920

654600

224077

2587653

739219

-654600

-224077

-2587653

-739219

106759

307402

33623

-497350

36126

30112

71855

61269

30382 15265 55345 15998

5580

2509

7688

4360

34671

259516

-101265

-578977

-619929

35439

-2688918

-1318196

-619929

35439

-2688918

-1318196

-619929

35439

-2688918

-1318196

-0.01

0.00

-0.02

-0.01

114355933

88839723

113447147

88940600

86782908

86783

43158248

43158

16999279

-18921169

-1791949

390140 390 131076 131466

1348951

1349

89951

91300

750000 750 -150000 -150 -600 214780 214780

-1353635

88881859

88882

43398388

43398

17434486

-20274804

-2708038

31251 31 21845 21876

60384

110

15344

15454

35439

88942243

88992

43429639

43429

17471675

-20239365

-2635269

108147731

108148

43283991

43284

18301472

-21044246

-2591342

4716000

4716

140985

145701

498155 498 23925 24423

95339

-2068989

113361886

113362

43283991

43284

18561721

-23113235

-4394868

113361886

113362

43283991

43284

18561721

-23113235

-4394868

1333334

1333

44013

45346

28147

-619929

114695220

114695

43283991

43284

18633881

-23733164

-4941304

114695220

114695

43283991

43284

18633881

-23733164

-4941304

941890

214780

-2688918

-1318196

7688

1851

66353

113255

1278600 146841

33623

-497350

-3551

349049

304065

428917 14315

-588383

-240519

18610

12668

-18610

-12668

191047

123486

-10000

-40070 261177

274463

251177

-332530

-2010

509914

5154

177384

3144

32043

214780

<p id="xdx_803_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zqdREO7emsFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NOTE 1 – BACKGROUND AND ORGANIZATION Business Operations Bioxytran, Inc. (“Bioxytran”, or the “Company”) is a clinical stage pharmaceutical company developing platform technologies in the fields of Glycovirology, Hypoxia and Degenerative Diseases to eliminate viruses and prolong lifespan using carbohydrate drug design. Bioxytran uses Galectin inhibitors to combat the virus, SARS-CoV-2. The technology is built on the lifetime work of company’s founder, David Platt, PhD. Dr. Platt expressed, and named, the Human Galectin-3 protein coded by a single gene, LGALS3, located on chromosome 14. Galectin inhibitors block the binding of galectins to carbohydrate structures, present in numerous disease indications by reducing the inflammatory feedback loop associated with the chronic diseases. The galectin inhibitors also have the capability to neutralize the spike proteins of a number of viruses which reduces their capability to replicate. Dr. Platt has over the years used this knowledge to create a significant number of sustainable therapeutic solutions. Bioxytran is also developing treatments for hypoxic conditions, necrosis, and degenerative diseases that utilize the carrying of oxygen to affected areas for stroke, wound, and brain damage treatment. Pharmalectin, Inc. (“Pharmalectin”) is a wholly owned subsidiary focused on the development, manufacture and commercialization of therapeutic drugs designed to address conditions related to viral diseases. NDPD Pharma, Inc. (“NDPD”) is a wholly owned subsidiary focused on prototyping and development of specialized equipment for pharmaceutical manufacturing, and in the development of carbohydrate molecules deriving from partially hydrolyzed guar gum (“PHGG”). Our wholly owned Subsidiary, Pharmalectin (BVI), Inc. (“Pharmalectin BVI”) is the owner and custodian of the Company’s Copyrights, Trade Marks and Patents. Our majority owned subsidiary, Pharmalectin India Pvt Ltd. (“Pharmalectin India”) is managing the Company’s local clinical research and trials, and holds the local rights to commercialization. Organization Bioxytran, Inc. was organized on October 5, 2017, as a Delaware corporation, with a taxing structure for U.S. federal and state income tax as a C-Corporation with 95,000,000 authorized Common shares with a par value of $0.0001, and 5,000,000 Preferred shares with a par value of $0.0001. On September 21, 2018, the Company went under a reorganization in the form of a reverse merger and is currently registered as a Nevada corporation with a taxing structure for U.S. federal and state income tax as a C-Corporation with 400,000,000 authorized Common shares with a par value of $0.001, and 50,000,000 Preferred shares with a par value of $0.001. Our Convertible Preferred Stock has a par value of $0.001 per share. The Preferred shares can at any time be converted into shares of Common Stock at a 1:5 basis, and carry a voting-power of an “as if converted” basis multiplied by a factor of two. Pharmalectin was organized on October 5, 2017, as a Delaware corporation, with a taxing structure for U.S. federal and state income tax as a C-Corporation with 95,000,000 authorized Common shares with a par value of $0.0001, and 5,000,000 Preferred shares with a par value of $0.0001. Pharmalectin was founded under the name of Bioxytran “Bioxytran (DE)”. On April 29, 2021, the name was changed to Pharmalectin, Inc. On August 19, 2024, the Company acquired the minority interest of Pharmalectin from officers of the Company. As at June 30, 2026, there are 15,000,000 shares of Common Stock issued and outstanding. NDPD Pharma was organized on October 5, 2017, as a Delaware corporation, with a taxing structure for U.S. federal and state income tax as a C-Corporation with 95,000,000 authorized shares of Common Stock with a par value of $0.0001, and 5,000,000 shares of Preferred Stock with a par value of $0.0001. On October 25, 2024, the Company acquired <span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20241025__us-gaap--BusinessAcquisitionAxis__custom--NDPDPharmaIncMember_zdIpfOgUrjIg" title="Common stock acquired percentage">100% of NDPD’s shares of Common Stock, the beneficial ownership of which included Company officers. As at June 30, 2026, there are 15,000,000 shares of Common Stock issued and outstanding. Pharmalectin BVI was organized on March 17, 2022 as a British Virgin Islands (BVI) Business Corporation with a BVI corporate taxing structure with 50,000 authorized shares with a par value of $1.00. There are currently 50,000 outstanding shares held by the Company. Pharmalectin India was organized on August 30, 2022 as an Indian Business Corporation with an India corporate taxing structure with <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20220830__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--PharmalectinIndiaPvtLtdMember_zNEzn7TL6VHg" title="Common stock, shares authorized">50,000 authorized shares with a par value of <span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uINRPShares_c20220830__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--PharmalectinIndiaPvtLtdMember_zL5trlKoMd5d" title="Common stock par value">10 Rupees. There are currently <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20220830__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--PharmalectinIndiaPvtLtdMember_zFavtIPYI2ai" title="Common stock, shares outstanding">41,020 outstanding shares, whereof <span id="xdx_906_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220830__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--PharmalectinIndiaPvtLtdMember_zEvBfyi7zy2e" title="Outstanding shares held">41,000 (<span id="xdx_903_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20220830__20220830__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--PharmalectinIndiaPvtLtdMember_zNrcLbzlMd6l" title="Outstanding shares percentage">99.95%) are held by the Company. Basis of Presentation The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements. Such financial statements and accompanying notes are the representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America (“U.S. GAAP”) in all material respects and have been consistently applied in preparing the accompanying consolidated financial statements. The Company has not earned any revenue from operations since inception. The Company chose December 31st as its fiscal year end. Principles of Consolidation The accompanying consolidated financial statements include the accounts of Bioxytran, Inc. a Nevada Corporation, its majority owned subsidiary, Pharmalectin, Inc. of Delaware (collectively, the “Company”), as well as its wholly owned subsidiaries, Pharmalectin (BVI), Inc of British Virgin Islands and Pharmalectin India Pvt Ltd. All intercompany accounts have been eliminated upon consolidation.

95000000

0.0001

5000000

0.0001

400000000

0.001

50000000

0.001

95000000

0.0001

5000000

0.0001

15000000

95000000

0.0001

5000000

0.0001

15000000

50000

1.00

50000

41020

41000

0.9995

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES A summary of the significant accounting policies applied in the preparation of the accompanying financial statements follows. Cash For purposes of the Statement of Cash Flows, the Company considers all highly liquid debt instruments purchased with a maturity date of three months or less to be cash equivalents. At June 30, 2026, the Company held cash balances totaling approximately $177,384, spread over 5 accounts. Deposits are insured by the FDIC up to $250,000 per institution. The Company’s cash balances periodically exceed this limit, resulting in nil uninsured deposits at quarter-end. While management monitors the creditworthiness of its banks, a failure of any institution could result in the loss of uninsured amounts. No such losses have occurred to date. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates. Net Loss per Common Share, basic and diluted The Company computes earnings (loss) per share under Accounting Standards Codification subtopic 260-10, Earnings Per Share (“ASC 260-10”). Net loss per common share is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding during the year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into Common Stock using the “treasury stock” and/or “if converted” methods as applicable. At June 30, 2026, we would, based on a Volume-Weighted Average Price (“VWAP”) of $0.0274/share, be obligated to issue approximately 68,412,956 shares of Common Stock upon conversion of the convertible note we issued in 2021 (the “2021 Note”), reset- and market closing adjustments not included, and 22,375,365 shares upon exercise of warrants, currently outstanding. Further, there are currently <span id="xdx_902_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z26IzGl44pi" title="Shares of Common Stock due for issuance">32,630,370 shares of Common Stock due for issuance. For the 2021 Note, the amount of shares are based on $<span id="xdx_90B_ecustom--CommonSharesIssuedForConversionOfNotesPayableAndAccruedInterest_pid_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zisAtAickcC2" title="Common shares issued for the conversion of principal and accrued interest">1,154,811 of principal and accrued interest currently outstanding. The 2021 Note issued on May 3, 2021, with its maturity date extended through March 1, 2025, carries an interest rate of 10%, with a default rate of 18%, and is convertible at the lower of (i) a fixed price of $0.08, or (ii) if the market price at the date of conversion is below $0.08, the conversion price will be reduced by 120% of the difference between the conversion price and the market price. The 2021 Note has been in default since March 1, 2025, with a default interest of 18%. Stock Based Compensation The Company measures the cost of services received from employees and non-employees in exchange for an award of equity instruments based on the fair value of the award on the grant date, defined as the bid price at the market closing on the prior day, pursuant ASC 718. Stock-based compensation expense is recorded by the Company in the same expense classifications in the statements of operations, as if such amounts were paid in cash. Research and Development The Company accounts for research and development costs in accordance with Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10”). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved as defined under the applicable agreement. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. During the six months ended June 30, 2026 the Company incurred $480,958 in research and development expenses, due to lack of funding, while during the six months ended June 30, 2025 the Company incurred $452,000. Intangibles – Goodwill and Other Valuation of intangibles are in accordance with ASC 350. Costs associated with the application and award of patents in the U.S. and various other countries are capitalized and amortized on a straight-line basis over the term of the patents as determined at award date, which varies depending on the pendency period of the application, generally approximating seventeen years. Capitalized patent costs, also referred to as patent prosecution costs, include internal legal labor, professional legal fees, government filing fees and translation fees related to expanding the Company’s patent portfolio. Costs associated with the maintenance and annuity fees of patents are accounted for as prepaid assets at the time of payment and amortized over the shorter of the maintenance period or remaining life of the related patent. Accrued Expenses As part of the process of preparing our consolidated financial statements, we are required to estimate accrued expenses. This process involves identifying services that third parties have performed on our behalf and estimating the level of service performed and the associated cost incurred on these services as at each balance sheet date in our consolidated financial statements. Examples of estimated accrued expenses include professional service fees, such as those arising from the services of attorneys and accountants and accrued payroll expenses. In connection with these service fees, our estimates are most affected by our understanding of the status and timing of services provided relative to the actual services incurred by the service providers. In the event that we do not identify certain costs that have been incurred or we under- or over-estimate the level of services or costs of such services, our reported expenses for a reporting period could be understated or overstated. The date on which certain services commence, the level of services performed on or before a given date, and the cost of services are often subject to our judgment. We make these judgments based upon the facts and circumstances known to us in accordance with accounting principles generally accepted in the U.S. Reclassification Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications had no impact on previously reported income or equity. Convertible Debt The Company accounts for convertible debt that does not meet the criteria for equity treatment in accordance with the guidance contained in ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Accordingly, the Company elected to classify the convertible debt as a liability at amortized cost using the effective interest method. The Company classifies convertible debt based on the re-payment terms and conditions. Any discounts on the convertible debt and costs incurred upon issuance of the convertible debt are amortized to interest expense over the terms of the related convertible debt. Convertible debt is also analyzed for the existence of embedded derivatives, which may require bifurcation from the convertible debt and separate accounting treatment. Refer to Note 8 for information regarding convertible debt. Embedded Derivatives The Company accounts for embedded derivatives in accordance with ASC 815-15, which requires separation of certain derivative-like features embedded in host contracts (such as convertible debt) when: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The economic characteristics of the embedded feature are not clearly and closely related to the host contract; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The hybrid instrument is not already measured at fair value.</td></tr> </table> The Company uses this method for calculations of Convertible debt with price-adjusted conversion features (e.g., reset provisions based on stock price declines) are bifurcated and measured at fair value through earnings, by applying a 100-step binomial lattice model incorporating stock price volatility, risk-free rates, and contractual adjustment terms. Changes in fair value of bifurcated derivatives are recognized in earnings each reporting period. Warrants The Company determines the accounting classification of warrants it issues as either liability or equity classified by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity (“ASC 480”), then in accordance with ASC 815-40 (“ASC 815”), Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock. Under ASC 480, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate the Company to settle the warrants or the underlying shares by paying cash or other assets, or warrants that must or may require settlement by issuing variable number of shares. If warrants do not meet liability classification under ASC 480, the Company assesses the requirements under ASC 815, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature. If the warrants do not require liability classification under ASC 815, and in order to conclude equity classification, the Company also assesses whether the warrants are indexed to its Common Stock and whether the warrants are classified as equity under ASC 815 or other applicable GAAP. After all relevant assessments, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants require fair value accounting at issuance and subsequent to initial issuance with all changes in fair value after the issuance date recorded in the statements of operations. Equity classified warrants only require fair value accounting at issuance with no changes recognized subsequent to the issuance date. The fair value of warrants is determined using the Black-Scholes option-pricing model using assumptions regarding volatility of our common share price, remaining life of the warrant, and risk-free interest rates at each period end. However, according to ASC 718-10-55-42 an exception would be if the fair value of one of the equity instruments (e.g., the share) is readily determinable and the other (e.g., the warrant) is not, the fair value of the instrument that is not readily determinable shall be measured using the residual method. Fair Value Accounting Standards Codification subtopic 825-10, Financial Instruments (“ASC 825-10”) requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable and accrued liabilities, and short-term borrowings, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed. The Company follows Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (“ASC 820-10”) and Accounting Standards Codification subtopic 825-10, Financial Instruments (“ASC 825-10”), which permits entities to choose to measure many financial instruments and certain other items at fair value. Under U.S. GAAP (specifically ASC 820, Fair Value Measurement), the fair value hierarchy prioritizes the inputs used in valuation techniques into three levels. Level 1 inputs have the highest priority and require the least disclosure, while Level 3 inputs have the lowest priority and require the most disclosure. Level 1 (Quoted Prices in Active Markets) Inputs: Unadjusted quoted prices for identical assets or liabilities in active markets (e.g., NYSE, NASDAQ) that the entity can access at the measurement date. Level 2 (Observable Inputs Other Than Quoted Prices) Inputs: Observable directly or indirectly for the asset/liability, but not quoted prices for identical items in active markets. Level 3 (Unobservable Inputs) Inputs: Unobservable inputs based on the entity’s own assumptions about what market participants would use (including risk assumptions). Used when observable inputs are not available. The valuation of shares issued under an exemption from registration, such as under Rule 3(a)(9) of the Securities Act, typically relates to ASC 820 (Fair Value Measurement) under U.S. Generally Accepted Accounting Principles (GAAP). This accounting standard provides guidance on how to measure fair value when required for financial reporting purposes. Among other notable considerations the Company highlights; When valuing shares in an exchange under Rule 3(a)(9), the conversion terms and the value of the securities being exchanged (debt, other equity, etc.) must be considered. If the company is offering a premium or discount as part of the exchange, this would impact the fair value measurement; Based on Empirical Evidence and Studies, for restricted stock in public companies, the liquidity discount averages around 20%–30%, based on, but not limited to, the following data; <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Liquidity of the Security:</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">If the company has low trading volumes and investors may find it difficult to sell shares, the discount could be on the higher end of the range (e.g., 30%–40%).</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Conversely, for OTC companies with higher trading volumes, the discount might be lower (e.g., 10%–20%).</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Holding Period:</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The longer the restriction period on the newly issued shares, the higher the discount. If the shares are subject to extended holding periods, investors will require greater compensation for their inability to sell the shares in the short term.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">For example, shares that are restricted for nine months under SEC Rule 144 could see a 20%–30% discount. If the holding period extends beyond that or other limitations apply, the discount might increase.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Company Fundamentals and Risk</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Investors consider the financial health, stability, and growth prospects of the issuing company. A riskier OTC company with volatile financials or uncertain growth prospects might see a larger liquidity discount (e.g., closer to 40%).</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Companies with strong fundamentals might experience a lower discount (e.g., 10%–20%), even in the OTC market.</td></tr> </table> In accordance with the guidance of ASC 820 concerning for Lack of Registration Premium, shares that are restricted for nine months under SEC Rule 144 generally see a 20%–30% discount on market price. The Company has opted for a 25% discount to the market price at the date of issuance based on the Company’s elevated volatility, and to the illiquidity of the large number of shares generally issued in these transactions. In contrary, shares issued under the registration requirements of the Securities Act for the Compensatory Benefit Plan pursuant to Rule 701 of the Securities Act where ASC 718 (Compensation—Stock Compensation), are valued at market price at the grant date, based on the limited number of shares awarded, and its predictable repetitiveness. Under ASC 718, the grant date is typically the measurement date for share-based compensation, the Company has interpreted this as the closing bid price on the market on the day preceding the grant, or award. This is the date when both parties (employer and employee) have a mutual understanding of the terms of the award, and it is used to determine the fair value of the stock-based award for accounting purposes. The fair value measured at the grant date is not adjusted for subsequent changes in stock price. Further, for derivatives under ASC 815, fair value is critical because these financial instruments (e.g., convertible note with a variable conversion rate) must be recorded at fair value on the balance sheet, with changes typically flowing through earnings. For the calculation of the derivative debt, the Company is using the Binomial Option Pricing model by Cox, Ross and Rubinstein. Recent Accounting Pronouncements There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s financial position, results of operations or cash flows.

Cash For purposes of the Statement of Cash Flows, the Company considers all highly liquid debt instruments purchased with a maturity date of three months or less to be cash equivalents. At June 30, 2026, the Company held cash balances totaling approximately $177,384, spread over 5 accounts. Deposits are insured by the FDIC up to $250,000 per institution. The Company’s cash balances periodically exceed this limit, resulting in nil uninsured deposits at quarter-end. While management monitors the creditworthiness of its banks, a failure of any institution could result in the loss of uninsured amounts. No such losses have occurred to date.

177384

250000

Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.

Net Loss per Common Share, basic and diluted The Company computes earnings (loss) per share under Accounting Standards Codification subtopic 260-10, Earnings Per Share (“ASC 260-10”). Net loss per common share is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding during the year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into Common Stock using the “treasury stock” and/or “if converted” methods as applicable. At June 30, 2026, we would, based on a Volume-Weighted Average Price (“VWAP”) of $0.0274/share, be obligated to issue approximately 68,412,956 shares of Common Stock upon conversion of the convertible note we issued in 2021 (the “2021 Note”), reset- and market closing adjustments not included, and 22,375,365 shares upon exercise of warrants, currently outstanding. Further, there are currently <span id="xdx_902_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20260630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_z26IzGl44pi" title="Shares of Common Stock due for issuance">32,630,370 shares of Common Stock due for issuance. For the 2021 Note, the amount of shares are based on $<span id="xdx_90B_ecustom--CommonSharesIssuedForConversionOfNotesPayableAndAccruedInterest_pid_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--PromissoryNotesMember_zisAtAickcC2" title="Common shares issued for the conversion of principal and accrued interest">1,154,811 of principal and accrued interest currently outstanding. The 2021 Note issued on May 3, 2021, with its maturity date extended through March 1, 2025, carries an interest rate of 10%, with a default rate of 18%, and is convertible at the lower of (i) a fixed price of $0.08, or (ii) if the market price at the date of conversion is below $0.08, the conversion price will be reduced by 120% of the difference between the conversion price and the market price. The 2021 Note has been in default since March 1, 2025, with a default interest of 18%.

0.0274

68412956

22375365

32630370

1154811

The 2021 Note issued on May 3, 2021, with its maturity date extended through March 1, 2025, carries an interest rate of 10%, with a default rate of 18%, and is convertible at the lower of (i) a fixed price of $0.08, or (ii) if the market price at the date of conversion is below $0.08, the conversion price will be reduced by 120% of the difference between the conversion price and the market price. The 2021 Note has been in default since March 1, 2025, with a default interest of 18%.

Stock Based Compensation The Company measures the cost of services received from employees and non-employees in exchange for an award of equity instruments based on the fair value of the award on the grant date, defined as the bid price at the market closing on the prior day, pursuant ASC 718. Stock-based compensation expense is recorded by the Company in the same expense classifications in the statements of operations, as if such amounts were paid in cash.

Research and Development The Company accounts for research and development costs in accordance with Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10”). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved as defined under the applicable agreement. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. During the six months ended June 30, 2026 the Company incurred $480,958 in research and development expenses, due to lack of funding, while during the six months ended June 30, 2025 the Company incurred $452,000.

480958

452000

Intangibles – Goodwill and Other Valuation of intangibles are in accordance with ASC 350. Costs associated with the application and award of patents in the U.S. and various other countries are capitalized and amortized on a straight-line basis over the term of the patents as determined at award date, which varies depending on the pendency period of the application, generally approximating seventeen years. Capitalized patent costs, also referred to as patent prosecution costs, include internal legal labor, professional legal fees, government filing fees and translation fees related to expanding the Company’s patent portfolio. Costs associated with the maintenance and annuity fees of patents are accounted for as prepaid assets at the time of payment and amortized over the shorter of the maintenance period or remaining life of the related patent.

Accrued Expenses As part of the process of preparing our consolidated financial statements, we are required to estimate accrued expenses. This process involves identifying services that third parties have performed on our behalf and estimating the level of service performed and the associated cost incurred on these services as at each balance sheet date in our consolidated financial statements. Examples of estimated accrued expenses include professional service fees, such as those arising from the services of attorneys and accountants and accrued payroll expenses. In connection with these service fees, our estimates are most affected by our understanding of the status and timing of services provided relative to the actual services incurred by the service providers. In the event that we do not identify certain costs that have been incurred or we under- or over-estimate the level of services or costs of such services, our reported expenses for a reporting period could be understated or overstated. The date on which certain services commence, the level of services performed on or before a given date, and the cost of services are often subject to our judgment. We make these judgments based upon the facts and circumstances known to us in accordance with accounting principles generally accepted in the U.S.

Reclassification Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications had no impact on previously reported income or equity.

Convertible Debt The Company accounts for convertible debt that does not meet the criteria for equity treatment in accordance with the guidance contained in ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Accordingly, the Company elected to classify the convertible debt as a liability at amortized cost using the effective interest method. The Company classifies convertible debt based on the re-payment terms and conditions. Any discounts on the convertible debt and costs incurred upon issuance of the convertible debt are amortized to interest expense over the terms of the related convertible debt. Convertible debt is also analyzed for the existence of embedded derivatives, which may require bifurcation from the convertible debt and separate accounting treatment. Refer to Note 8 for information regarding convertible debt.

Embedded Derivatives The Company accounts for embedded derivatives in accordance with ASC 815-15, which requires separation of certain derivative-like features embedded in host contracts (such as convertible debt) when: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The economic characteristics of the embedded feature are not clearly and closely related to the host contract; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The hybrid instrument is not already measured at fair value.</td></tr> </table> The Company uses this method for calculations of Convertible debt with price-adjusted conversion features (e.g., reset provisions based on stock price declines) are bifurcated and measured at fair value through earnings, by applying a 100-step binomial lattice model incorporating stock price volatility, risk-free rates, and contractual adjustment terms. Changes in fair value of bifurcated derivatives are recognized in earnings each reporting period.

Warrants The Company determines the accounting classification of warrants it issues as either liability or equity classified by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity (“ASC 480”), then in accordance with ASC 815-40 (“ASC 815”), Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock. Under ASC 480, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate the Company to settle the warrants or the underlying shares by paying cash or other assets, or warrants that must or may require settlement by issuing variable number of shares. If warrants do not meet liability classification under ASC 480, the Company assesses the requirements under ASC 815, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature. If the warrants do not require liability classification under ASC 815, and in order to conclude equity classification, the Company also assesses whether the warrants are indexed to its Common Stock and whether the warrants are classified as equity under ASC 815 or other applicable GAAP. After all relevant assessments, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants require fair value accounting at issuance and subsequent to initial issuance with all changes in fair value after the issuance date recorded in the statements of operations. Equity classified warrants only require fair value accounting at issuance with no changes recognized subsequent to the issuance date. The fair value of warrants is determined using the Black-Scholes option-pricing model using assumptions regarding volatility of our common share price, remaining life of the warrant, and risk-free interest rates at each period end. However, according to ASC 718-10-55-42 an exception would be if the fair value of one of the equity instruments (e.g., the share) is readily determinable and the other (e.g., the warrant) is not, the fair value of the instrument that is not readily determinable shall be measured using the residual method.

Fair Value Accounting Standards Codification subtopic 825-10, Financial Instruments (“ASC 825-10”) requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable and accrued liabilities, and short-term borrowings, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed. The Company follows Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (“ASC 820-10”) and Accounting Standards Codification subtopic 825-10, Financial Instruments (“ASC 825-10”), which permits entities to choose to measure many financial instruments and certain other items at fair value. Under U.S. GAAP (specifically ASC 820, Fair Value Measurement), the fair value hierarchy prioritizes the inputs used in valuation techniques into three levels. Level 1 inputs have the highest priority and require the least disclosure, while Level 3 inputs have the lowest priority and require the most disclosure. Level 1 (Quoted Prices in Active Markets) Inputs: Unadjusted quoted prices for identical assets or liabilities in active markets (e.g., NYSE, NASDAQ) that the entity can access at the measurement date. Level 2 (Observable Inputs Other Than Quoted Prices) Inputs: Observable directly or indirectly for the asset/liability, but not quoted prices for identical items in active markets. Level 3 (Unobservable Inputs) Inputs: Unobservable inputs based on the entity’s own assumptions about what market participants would use (including risk assumptions). Used when observable inputs are not available. The valuation of shares issued under an exemption from registration, such as under Rule 3(a)(9) of the Securities Act, typically relates to ASC 820 (Fair Value Measurement) under U.S. Generally Accepted Accounting Principles (GAAP). This accounting standard provides guidance on how to measure fair value when required for financial reporting purposes. Among other notable considerations the Company highlights; When valuing shares in an exchange under Rule 3(a)(9), the conversion terms and the value of the securities being exchanged (debt, other equity, etc.) must be considered. If the company is offering a premium or discount as part of the exchange, this would impact the fair value measurement; Based on Empirical Evidence and Studies, for restricted stock in public companies, the liquidity discount averages around 20%–30%, based on, but not limited to, the following data; <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Liquidity of the Security:</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">If the company has low trading volumes and investors may find it difficult to sell shares, the discount could be on the higher end of the range (e.g., 30%–40%).</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Conversely, for OTC companies with higher trading volumes, the discount might be lower (e.g., 10%–20%).</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Holding Period:</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The longer the restriction period on the newly issued shares, the higher the discount. If the shares are subject to extended holding periods, investors will require greater compensation for their inability to sell the shares in the short term.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">For example, shares that are restricted for nine months under SEC Rule 144 could see a 20%–30% discount. If the holding period extends beyond that or other limitations apply, the discount might increase.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Company Fundamentals and Risk</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Investors consider the financial health, stability, and growth prospects of the issuing company. A riskier OTC company with volatile financials or uncertain growth prospects might see a larger liquidity discount (e.g., closer to 40%).</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">-</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Companies with strong fundamentals might experience a lower discount (e.g., 10%–20%), even in the OTC market.</td></tr> </table> In accordance with the guidance of ASC 820 concerning for Lack of Registration Premium, shares that are restricted for nine months under SEC Rule 144 generally see a 20%–30% discount on market price. The Company has opted for a 25% discount to the market price at the date of issuance based on the Company’s elevated volatility, and to the illiquidity of the large number of shares generally issued in these transactions. In contrary, shares issued under the registration requirements of the Securities Act for the Compensatory Benefit Plan pursuant to Rule 701 of the Securities Act where ASC 718 (Compensation—Stock Compensation), are valued at market price at the grant date, based on the limited number of shares awarded, and its predictable repetitiveness. Under ASC 718, the grant date is typically the measurement date for share-based compensation, the Company has interpreted this as the closing bid price on the market on the day preceding the grant, or award. This is the date when both parties (employer and employee) have a mutual understanding of the terms of the award, and it is used to determine the fair value of the stock-based award for accounting purposes. The fair value measured at the grant date is not adjusted for subsequent changes in stock price. Further, for derivatives under ASC 815, fair value is critical because these financial instruments (e.g., convertible note with a variable conversion rate) must be recorded at fair value on the balance sheet, with changes typically flowing through earnings. For the calculation of the derivative debt, the Company is using the Binomial Option Pricing model by Cox, Ross and Rubinstein.

0.25

Recent Accounting Pronouncements There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s financial position, results of operations or cash flows.

NOTE 3 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS As at June 30, 2026, the Company had cash of $177,384 and a negative working capital of $5,097,313. As at June 30, 2026, the Company has not yet generated any revenues from operations, and has incurred an accumulated deficit of $23,733,164. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. During the six months ended June 30, 2026, the Company raised a total of $314,533 through private placements consisting of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znbT54b5Dh16" title="Proceeds from private placement">191,047 in stock and $123,486 in warrants to purchase Common Stock, while repaying $40,070 in an affiliate loan. During the same period in 2025, the Company raised $261,177 in short-term loans from affiliates and reimbursed a short-term loan of $10,000. The Company is aware that its current cash on hand will not be sufficient to fund its projected operating requirements through the month of September 2026 and is pursuing alternative opportunities to funding. The Company intends to raise additional capital through private placements of debt and/or equity securities, but there can be no assurance that these funds will be available on terms acceptable to the Company, or will be sufficient to enable the Company to fully complete its development activities or sustain operations. If the Company is unable to raise sufficient additional funds, it will have to develop and implement a plan to further extend payables, reduce overhead, or scale back its current business plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful. Accordingly, the accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.

177384

-5097313

-23733164

314533

191047

123486

40070

261177

-10000

NOTE 4: SINGLE SEGMENT DISCLOSURE For the six months ended June 30, 2026 In accordance with Accounting Standards Codification ASC 218, Segment Reporting, the Company has determined that it operates as a single operating segment. The Company’s Chief Operating Decision Maker (“CODM”), which is its Chief Executive Officer, reviews the Company’s financial performance and allocates resources on a consolidated basis. The Company’s operations focus solely on pharmaceutical research and development activities, and it does not manage the business using multiple segments or by product lines. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">i.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Revenue and Geographic Information: As of June 30, 2026, the Company has not yet generated significant revenues from its pharmaceutical products as it remains in the research and development phase. Consequently, there is no dis-aggregation of revenue by geographic area or product line.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">ii.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Major Customers and Concentration of Risk: Since the Company is in the development phase and has not generated revenue from product sales, there are no major customers to report. The Company is reliant on funding through private placements, equity offerings, and other financial arrangements to sustain its research and development efforts.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">iii.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Long-lived Assets by Geographic Region: The Company’s tangible and intangible assets, including intellectual property and research-related equipment, are located within the United States and BVI. However, these assets do not represent a significant portion of the Company’s total assets.</td></tr> </table> Conclusion: The Company has concluded that it qualifies as a single reportable segment under ASC 218 based on the nature of its operations, the way it is managed, and the financial information reviewed by the CODM. As such, no additional segment disclosures are required in the consolidated financial statements.

NOTE 5 - AFFILIATES TRANSACTIONS On January 30, 2026, the Company granted <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20260130__20260130__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember__srt--TitleOfIndividualAxis__custom--DavidPlattMember_zMIBDIH7EZp9" title="Number of shares granted">6,000,000 shares of the Company’s Convertible Preferred Stock to Dr. Platt as a performance grant in recognition of his role in executing the Company’s first commercial distribution agreement and advancing capital funding initiatives. The shares are not yet issued. The Company holds a License Agreement (the “License” or “Agreement”) for a medical device (license obtained in 2019) with an affiliated company in which Company officers hold a majority interest. The device was developed prior to the establishment of Bioxytran. The annual maintenance cost for the license amounts to $5,000.

6000000

5000

NOTE 6 - INTANGIBLES Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. No impairment charges were recorded at June 30, 2026, and December 31, 2025. Amortization of capitalized patent costs associated with the application and award of patents in the U.S. and various other countries are capitalized and amortized on a straight-line basis over the term of the patents as determined at the award date, which varies depending on the pendency period of the application, generally approximating seventeen years. The current patent application is still in process, and is therefore not yet amortized. SCHEDULE OF INTANGIBLES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Estimated Remaining Life (years)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260630_zpgQKNv7u4zb" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20251231_zlxnNJuWbIo" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maFLIANzcPY_maFLIANz1HT_zCmsxhWJEovd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 42%; text-align: left">Capitalized patent costs</td><td style="width: 2%"> </td> <td style="width: 16%; text-align: center">14.2</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">195,120</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">176,509</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msFLIANzcPY_msFLIANz1HT_zU6XCTCe8Ne" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(39,111</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(31,423</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANz1HT_zBQv0h9y9DAf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Intangible assets, net</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">156,009</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">145,087</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

SCHEDULE OF INTANGIBLES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Estimated Remaining Life (years)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260630_zpgQKNv7u4zb" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20251231_zlxnNJuWbIo" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maFLIANzcPY_maFLIANz1HT_zCmsxhWJEovd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 42%; text-align: left">Capitalized patent costs</td><td style="width: 2%"> </td> <td style="width: 16%; text-align: center">14.2</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">195,120</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">176,509</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msFLIANzcPY_msFLIANz1HT_zU6XCTCe8Ne" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(39,111</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(31,423</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANz1HT_zBQv0h9y9DAf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Intangible assets, net</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">156,009</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">145,087</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

P14Y2M12D

195120

176509

39111

31423

156009

145087

<p id="xdx_80E_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zvoQxGLd4Lec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NOTE 7 – ACCOUNTS PAYABLES AND ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES On June 30, 2026, there was $<span id="xdx_904_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zFp4dMww3bk9" title="Accounts payable to related parties">1,001,115 due in form of accrued liabilities and accounts payable to affiliates. Further there was a short-term loan from affiliates of $355,598 and $75,761 in accrued interest. On December 31, 2025, there was $577,500 in form of accrued liabilities and accounts payable while the short-term loan amounted to $395,668 and the accrued interest $52,459. The following table represents the major components of accounts payable and accrued expenses and other current liabilities at June 30, 2026, and December 31, 2025: SCHEDULE OF ACCOUNTS PAYABLES AND ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20260630_zRNl0Hfhxvr" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20251231_za9ziWWGATn7" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_ecustom--AccruedPayrollAffiliatesCurrent_iI_maLCzsPB_z7wXwLP4rEGc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Affiliate liabilities (1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,001,115</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">577,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_iI_maLCzsPB_ziHyNHgn2J15" style="vertical-align: bottom; background-color: White"> <td>Pension/401K</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">195,786</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">114,534</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccruedPayrollTaxesCurrent_iI_maLCzsPB_zUFXqO2YOeY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Payroll tax reserve</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,448</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,787</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--AccountsPayableExcludingInterestCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzsPB_zCEfqur6apHh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts payable affiliates (1)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrent_iI_maLCzsPB_zpzUyOCyume6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">574,961</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">412,521</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_maLCzsPB_z1ycmVv1Lsrh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">679</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">838</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InterestPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzsPB_zUS1zd9A3hzf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Interest affiliates (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,761</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,459</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_maLCzsPB_znYF8IrgbLak" style="vertical-align: bottom; background-color: White"> <td>Interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">349,811</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">277,956</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredCompensationShareBasedArrangementsLiabilityCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzsPB_zBQguIIkzhb3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Un-issued shares affiliates (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,360,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">82,006</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredCompensationShareBasedArrangementsLiabilityCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_maLCzsPB_zpzFikNYYJ51" style="vertical-align: bottom; background-color: White"> <td>Un-issued shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,202</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,272</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LoansPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzsPB_zUqQR7ATdTk4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loan from affiliates (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">355,598</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">395,668</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherShortTermBorrowings_iI_maLCzsPB_zrI3yv6RH1Rf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short term loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--ConvertibleNotesPayableCurrent_iI_maLCzsPB_zzpCPemvpykf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">805,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">805,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DerivativeLiabilitiesCurrent_iI_maLCzsPB_zWyHBadgH88l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">369,730</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">403,353</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LiabilitiesCurrent_iTI_mtLCzsPB_zJL7cdsVcw69" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,274,697</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,249,894</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">To the CFO and CEO, there was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20260630__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zJ7pTNLUxlS2" title="Accrued liabilities">843,615 and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20251231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zp5pecqtwYP8" title="Accrued liabilities">427,000 in accrued payroll as of June 30, 2026 and December 31, 2025, respectively. As of June 30, 2026, and at December 31, 2025, the Company had recorded reserves for contingent compensation claims of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20260101__20260630__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zApmqe6C4mxk" title="Compensation claims">157,500 and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20250101__20251231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zc641Nv9Oued" title="Compensation claims">11,000 relating to disputed compensation and expense reimbursement claims asserted by the former Chief Commercial Officer and current shareholder. These amounts reflect management’s reserve associated with a disputed matter and do not represent routine accrued payroll obligations incurred in the ordinary course.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">As of June 30, 2026, the amount to be converted into shares of Preferred Stock is $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zQctObw410bc" title="Stock issued during period value conversion of convertible securities">1,360,606. This consist of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zSIQRpFzFhX5" title="Stock issued during period value conversion of convertible securities">82,006 is to our Directors for their attendance at board and committee meetings during the fourth quarter and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zBVDxpiG7Qvj" title="Stock issued during period value conversion of convertible securities">1,278,600 to Dr. Platt as a performance grant in recognition of his role in executing the Company’s first commercial distribution agreement and advancing capital funding initiatives. On December 31, 2025 this amount was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zKJFpuersuBd" title="Stock issued during period value conversion of convertible securities">82,006.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On June 30, 2026, the Company has a $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtCurrent_iI_c20260630__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zBalmEbSHrHh" title="Loam amount">355,598 loan from an affiliated company with an interest rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20260630__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_z0VdCMM5h2ze" title="Interest rate">8%. The accrued interest is currently $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20260101__20260630__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zwrehliGVL59" title="Accrued interest">75,761. On December 31, 2025, the Company the loan was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--DebtCurrent_iI_c20251231__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zEXMStwELBak" title="Loam amount">395,668 and the accrued interest $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20250101__20251231__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zrgBYfEFS1kb" title="Accrued interest">52,459.</td></tr> </table>

1001115

355598

75761

577500

395668

52459

The following table represents the major components of accounts payable and accrued expenses and other current liabilities at June 30, 2026, and December 31, 2025: SCHEDULE OF ACCOUNTS PAYABLES AND ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20260630_zRNl0Hfhxvr" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20251231_za9ziWWGATn7" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_400_ecustom--AccruedPayrollAffiliatesCurrent_iI_maLCzsPB_z7wXwLP4rEGc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Affiliate liabilities (1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,001,115</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">577,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_iI_maLCzsPB_ziHyNHgn2J15" style="vertical-align: bottom; background-color: White"> <td>Pension/401K</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">195,786</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">114,534</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccruedPayrollTaxesCurrent_iI_maLCzsPB_zUFXqO2YOeY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Payroll tax reserve</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,448</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,787</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--AccountsPayableExcludingInterestCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzsPB_zCEfqur6apHh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts payable affiliates (1)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrent_iI_maLCzsPB_zpzUyOCyume6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">574,961</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">412,521</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_maLCzsPB_z1ycmVv1Lsrh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">679</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">838</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InterestPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzsPB_zUS1zd9A3hzf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Interest affiliates (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,761</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,459</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_maLCzsPB_znYF8IrgbLak" style="vertical-align: bottom; background-color: White"> <td>Interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">349,811</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">277,956</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredCompensationShareBasedArrangementsLiabilityCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzsPB_zBQguIIkzhb3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Un-issued shares affiliates (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,360,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">82,006</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredCompensationShareBasedArrangementsLiabilityCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_maLCzsPB_zpzFikNYYJ51" style="vertical-align: bottom; background-color: White"> <td>Un-issued shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,202</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,272</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LoansPayableCurrent_iI_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzsPB_zUqQR7ATdTk4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loan from affiliates (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">355,598</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">395,668</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherShortTermBorrowings_iI_maLCzsPB_zrI3yv6RH1Rf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short term loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--ConvertibleNotesPayableCurrent_iI_maLCzsPB_zzpCPemvpykf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">805,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">805,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DerivativeLiabilitiesCurrent_iI_maLCzsPB_zWyHBadgH88l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">369,730</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">403,353</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LiabilitiesCurrent_iTI_mtLCzsPB_zJL7cdsVcw69" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,274,697</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,249,894</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">To the CFO and CEO, there was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20260630__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zJ7pTNLUxlS2" title="Accrued liabilities">843,615 and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20251231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zp5pecqtwYP8" title="Accrued liabilities">427,000 in accrued payroll as of June 30, 2026 and December 31, 2025, respectively. As of June 30, 2026, and at December 31, 2025, the Company had recorded reserves for contingent compensation claims of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20260101__20260630__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zApmqe6C4mxk" title="Compensation claims">157,500 and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20250101__20251231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zc641Nv9Oued" title="Compensation claims">11,000 relating to disputed compensation and expense reimbursement claims asserted by the former Chief Commercial Officer and current shareholder. These amounts reflect management’s reserve associated with a disputed matter and do not represent routine accrued payroll obligations incurred in the ordinary course.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">As of June 30, 2026, the amount to be converted into shares of Preferred Stock is $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zQctObw410bc" title="Stock issued during period value conversion of convertible securities">1,360,606. This consist of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zSIQRpFzFhX5" title="Stock issued during period value conversion of convertible securities">82,006 is to our Directors for their attendance at board and committee meetings during the fourth quarter and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20251001__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zBVDxpiG7Qvj" title="Stock issued during period value conversion of convertible securities">1,278,600 to Dr. Platt as a performance grant in recognition of his role in executing the Company’s first commercial distribution agreement and advancing capital funding initiatives. On December 31, 2025 this amount was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zKJFpuersuBd" title="Stock issued during period value conversion of convertible securities">82,006.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On June 30, 2026, the Company has a $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--DebtCurrent_iI_c20260630__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zBalmEbSHrHh" title="Loam amount">355,598 loan from an affiliated company with an interest rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20260630__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_z0VdCMM5h2ze" title="Interest rate">8%. The accrued interest is currently $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20260101__20260630__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zwrehliGVL59" title="Accrued interest">75,761. On December 31, 2025, the Company the loan was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--DebtCurrent_iI_c20251231__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zEXMStwELBak" title="Loam amount">395,668 and the accrued interest $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDQ09VTlRTIFBBWUFCTEVTIEFORCBBQ0NSVUVEIEVYUEVOU0VTIEFORCBPVEhFUiBDVVJSRU5UIExJQUJJTElUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20250101__20251231__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zrgBYfEFS1kb" title="Accrued interest">52,459.</td></tr> </table>

1001115 577500

195786

114534

66448

43787

11000 18000

574961

412521

679

838

75761

52459

349811

277956

1360606

82006

58202

16272

355598

395668

50000

805000

369730

403353

5274697

3249894

843615

427000

157500

11000

1360606

82006

1278600

82006

355598

0.08

75761

395668

52459

NOTE 8 – CONVERTIBLE NOTES PAYABLE Around May 3, 2021, we entered into four (4) Securities Purchase Agreements (the “2021 SPA’s”), under which we agreed to sell convertible promissory notes (the “2021 Notes”), in an aggregate principal amount of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20210503__us-gaap--TypeOfArrangementAxis__custom--FourSecuritiesPurchaseAgreementsMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyOneNotesMember_zGzEd0HKmF3f" title="Aggregate principal amount">2,165,000 with <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210503__us-gaap--TypeOfArrangementAxis__custom--FourSecuritiesPurchaseAgreementsMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyOneNotesMember_zWVBKM8k1U6f" title="Interest rate">6% interest. At any time after the issue date of the 2021 Notes, the Holders of the 2012 Notes, (the “2021 Holders”), have the option to convert all or any part of the outstanding and unpaid principal amount and accrued and unpaid interest of the 2021 Notes into shares of our Common Stock at the Conversion Price. <span id="xdx_908_eus-gaap--DebtConversionDescription_c20210503__20210503__us-gaap--TypeOfArrangementAxis__custom--FourSecuritiesPurchaseAgreementsMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyOneNotesMember_zaCUIPEybKhh" title="Note conversion description">The “Conversion Price” will be the lesser of (i) $.13 per share or (ii) if the market price at the date of conversion is below $0.13, the conversion price will be reduced by 120% of the difference between the conversion price and the market price. If the 2021 Notes are converted prior to us paying off such note, it would lead to substantial dilution to our shareholders as a result of the conversion discounted applicable to the 2021 Notes. There can be no assurance that there will be any funds available to pay off the 2021 Notes. If we fail to obtain such additional financing on a timely basis, the 2021 Holders may convert the 2021 Notes and sell the underlying shares, which may result in significant dilution to shareholders due to the conversion discount, as well as a significant decrease in our stock price. On May 5, 2023, three (3) of the Notes were renegotiated; the interest was set to <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230505__us-gaap--TypeOfArrangementAxis__custom--ThreeNotesMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zjUoHTDfHGyj" title="Interest rate">10% (default rate <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_pid_dp_uPure_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--ThreeNotesMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zkTXgfvPiA13" title="Default Interest rate">18%), a prepayment at <span id="xdx_90B_ecustom--PrepaymentPercentage_iI_pid_dp_uPure_c20230505__us-gaap--TypeOfArrangementAxis__custom--ThreeNotesMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zZzTRiYUELg1" title="Prepayment percentage">120% was included and the Notes extended until <span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_dd_c20230505__20230505__us-gaap--TypeOfArrangementAxis__custom--ThreeNotesMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ztrrDllW4ld1" title="Notes extended date">April 30, 2024. Two of the notes were fully converted and on July 15, 2024, a debt discount of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240715__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--ThreeNotesMember_zwVHJNWeC5Gh" title="Debt discount">105,000 was added to the remaining notes principal and the Base Conversion Price was reset to $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240715__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--ThreeNotesMember_zTXRg0Vhy9Ze" title="Conversion Price">0.08. The last outstanding note issued in 2021 has been in default since March 1, 2025, with a default interest of 18%. At June 30, 2026, and December 31, 2025, the outstanding convertible notes were as follows: SCHEDULE OF OUTSTANDING CONVERTIBLE NOTES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name</td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal due</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accrued interest</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total amount due</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: center"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left">Notes sold in exchange for cash</td> <td style="width: 6%; text-align: center">(1)</td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_zu2rlUrbae8" style="width: 12%; text-align: right" title="Total principal due">805,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_z3BC1ItCNDgg" style="width: 12%; text-align: right" title="Total accrued interest">277,956</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_c20251231__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_zb4ti2kttFo3" style="width: 12%; text-align: right" title="Total amount due">1,082,956</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td> <td style="text-align: center"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: center"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Notes sold in exchange for cash</td> <td style="text-align: center">(1)</td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DebtInstrumentFaceAmount_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_zc8Opq7VPCM6" style="text-align: right" title="Total principal due">805,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_zCEdVrMbZc7b" style="text-align: right" title="Total accrued interest">349,811</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_zdRLmkw9wgRd" style="text-align: right" title="Total amount due">1,154,811</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The note was sold on May 3, 2021 with a face value of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIENPTlZFUlRJQkxFIE5PVEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20210503_zTf7i7pi16tl" title="Face value">1,000,000 and debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIENPTlZFUlRJQkxFIE5PVEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_c20210503__20210503_z7wzZ6RqeuA6" title="Debt discount">102,875 paid to the sole Placement Agent: WallachBeth Capital, LLC (Member FINRA / SIPC).</td></tr> </table>

2165000

0.06

The “Conversion Price” will be the lesser of (i) $.13 per share or (ii) if the market price at the date of conversion is below $0.13, the conversion price will be reduced by 120% of the difference between the conversion price and the market price.

0.10

0.18

1.20

2024-04-30

105000

0.08

0.18

At June 30, 2026, and December 31, 2025, the outstanding convertible notes were as follows: SCHEDULE OF OUTSTANDING CONVERTIBLE NOTES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name</td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal due</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accrued interest</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total amount due</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: center"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left">Notes sold in exchange for cash</td> <td style="width: 6%; text-align: center">(1)</td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--DebtInstrumentFaceAmount_iI_c20251231__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_zu2rlUrbae8" style="width: 12%; text-align: right" title="Total principal due">805,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_z3BC1ItCNDgg" style="width: 12%; text-align: right" title="Total accrued interest">277,956</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_c20251231__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_zb4ti2kttFo3" style="width: 12%; text-align: right" title="Total amount due">1,082,956</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td> <td style="text-align: center"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: center"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Notes sold in exchange for cash</td> <td style="text-align: center">(1)</td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--DebtInstrumentFaceAmount_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_zc8Opq7VPCM6" style="text-align: right" title="Total principal due">805,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_zCEdVrMbZc7b" style="text-align: right" title="Total accrued interest">349,811</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--NoteSoldInExchangeForCashMember_fKDEp_zdRLmkw9wgRd" style="text-align: right" title="Total amount due">1,154,811</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The note was sold on May 3, 2021 with a face value of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIENPTlZFUlRJQkxFIE5PVEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20210503_zTf7i7pi16tl" title="Face value">1,000,000 and debt discount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIENPTlZFUlRJQkxFIE5PVEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_c20210503__20210503_z7wzZ6RqeuA6" title="Debt discount">102,875 paid to the sole Placement Agent: WallachBeth Capital, LLC (Member FINRA / SIPC).</td></tr> </table>

805000

277956

1082956

805000

349811

1154811

1000000

102875

NOTE 9 – CONVERTIBLE NOTE AND EMBEDDED DERIVATIVE Convertible Note Terms The Company has outstanding convertible debt with the following key terms: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Principal Amount: $1,154,811 (including accrued interest)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Lower of Conversion Price, $0.08, & Reset price, $0.0421 per share of Common Stock</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Maturity Date: March 1, 2025</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Lower of VWAP, $0.0274, & Market closing, $0.026 per share of Common Stock</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Price Adjustment Feature: If the market price at conversion is below $0.08, the conversion price will be reduced by 120% of the difference between the conversion price and VWAP, price adjusted for fluctuation in reset- and market closing price </td></tr></table> Embedded Derivative Classification The price adjustment feature meets the criteria for bifurcation as an embedded derivative under ASC 815-15-25-1 because: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">It is not clearly and closely related to the host debt instrument.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The 120% adjustment creates a non-linear payoff linked to the stock price.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">It is required to be separately accounted for at fair value with changes recorded in earnings.</td></tr> </table> Valuation Technique The company has used a 100-step binomial lattice model for its valuations. The binomial model captures: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Path dependency of the adjustment feature.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Optimal conversion behavior (American-style exercise).</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Probability-weighted payoffs under risk-neutral valuation.</td></tr> </table> Fair Value Measurement of Embedded Derivative The fair value measurement of the derivative is classified within Level 3 of the fair value hierarchy established by ASC 820-10-35-37 through ASC 820-10-35-54A, as the valuation inputs include unobservable inputs (expected volatility) that are significant to the overall measurement. The derivative liability on the note was at June 30, 2026, valued at $369,730, while principal amount was $1,154,811 (including accrued interest). On December 31, 2025, the notes principal amount was $1,082,956 (including accrued interest), the derivative liability was valued at $403,353. The following key inputs were used in the derivative debt calculation: SCHEDULE OF FAIR VALUE MEASUREMENT OF EMBEDDED DERIVATIVE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Parameter</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Source/Methodology</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: justify">Current Stock Price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20260630_zkX54vAYCHz6" style="width: 16%; text-align: right" title="Current Stock Price">0.0260</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20251231_z6PbSQvkmkfl" style="width: 16%; text-align: right" title="Current Stock Price">0.0758</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 39%">Observable market price</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Conversion Price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20260630_zSatggwAnjy6" style="text-align: right" title="Conversion Price">0.0249</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20251231_zBvheX7xm668" style="text-align: right" title="Conversion Price">0.0692</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">Contractual terms</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20260101__20260630_zYIYnAgnQFx6" style="text-align: right" title="Volatility">103.50</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20250101__20251231_zA47NYdI5ej6" style="text-align: right" title="Volatility">109.45</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">Historical volatility of comparable companies</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk-Free Rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20260101__20260630_fKg_____z5ZkQIigTy3d" style="text-align: right" title="Risk-Free Rate">4.01</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20250101__20251231_fKg_____zKPXtS0jDVCd" style="text-align: right" title="Risk-Free Rate">3.59</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">1.5-month (6-month)* U.S. Treasury yield</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Time to Maturity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">default</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">default</td><td style="text-align: left"> </td><td> </td> <td>6 months*</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Adjustment Multiplier</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--AdjustmentMultiplierRate_pid_dp_uPure_c20260101__20260630_zJQbloUTQAv" style="text-align: right" title="Adjustment Multiplier">120</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--AdjustmentMultiplierRate_pid_dp_uPure_c20250101__20251231_zBgLxiVUEOqi" style="text-align: right" title="Adjustment Multiplier">120</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">Contractual terms</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">*</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The number of months used in the calculation to estimate the value of the derivative debt.</td></tr> </table> For the three months ended June 30, 2026, the estimated change in fair value reduced the derivative liability by $(106,759), while for the six months ended June 30, 2026, the estimate of the change in fair value reduced the derivative liability by $(33,623). Sensitivity and Risks <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Volatility Impact: A 20% increase in volatility to 124.19% would increase the derivative liability by $64,343.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Stock Price Risk: A 20% increase of the stock price to $0.0329 would reduce the derivative liability by $46,423.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Concentration Risk: The value of the derivative liability is significantly higher that the instrument itself, which highlights a potential equity dilution.</td></tr> </table>

1154811

0.08

0.0421

2025-03-01

0.0274

0.026

0.08

1.20

369730

1154811

1082956

403353

SCHEDULE OF FAIR VALUE MEASUREMENT OF EMBEDDED DERIVATIVE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Parameter</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Source/Methodology</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%; text-align: justify">Current Stock Price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20260630_zkX54vAYCHz6" style="width: 16%; text-align: right" title="Current Stock Price">0.0260</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20251231_z6PbSQvkmkfl" style="width: 16%; text-align: right" title="Current Stock Price">0.0758</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 39%">Observable market price</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Conversion Price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20260630_zSatggwAnjy6" style="text-align: right" title="Conversion Price">0.0249</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20251231_zBvheX7xm668" style="text-align: right" title="Conversion Price">0.0692</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">Contractual terms</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20260101__20260630_zYIYnAgnQFx6" style="text-align: right" title="Volatility">103.50</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20250101__20251231_zA47NYdI5ej6" style="text-align: right" title="Volatility">109.45</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">Historical volatility of comparable companies</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk-Free Rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20260101__20260630_fKg_____z5ZkQIigTy3d" style="text-align: right" title="Risk-Free Rate">4.01</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20250101__20251231_fKg_____zKPXtS0jDVCd" style="text-align: right" title="Risk-Free Rate">3.59</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">1.5-month (6-month)* U.S. Treasury yield</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Time to Maturity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">default</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">default</td><td style="text-align: left"> </td><td> </td> <td>6 months*</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Adjustment Multiplier</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--AdjustmentMultiplierRate_pid_dp_uPure_c20260101__20260630_zJQbloUTQAv" style="text-align: right" title="Adjustment Multiplier">120</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--AdjustmentMultiplierRate_pid_dp_uPure_c20250101__20251231_zBgLxiVUEOqi" style="text-align: right" title="Adjustment Multiplier">120</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">Contractual terms</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">*</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The number of months used in the calculation to estimate the value of the derivative debt.</td></tr> </table>

0.0260

0.0758

0.0249

0.0692

1.0350

1.0945

0.0401

0.0359

1.20 1.20

106759

33623

Volatility Impact: A 20% increase in volatility to 124.19% would increase the derivative liability by $64,343.

Stock Price Risk: A 20% increase of the stock price to $0.0329 would reduce the derivative liability by $46,423.

Concentration Risk: The value of the derivative liability is significantly higher that the instrument itself, which highlights a potential equity dilution. NOTE 10 – ALLOCATION OF FAIR VALUE IN PRIVATE PLACEMENT Unit Offering During the period from October 30, 2025, to May 8, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2j9VSAZeAne" title="Stock price per share">0.051 per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised a total of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfWarrants_c20251030__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zzNKCxgiC7wc" title="Proceeds from issuance of warrants">1,032,240 (after $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRe2Om1BaQGe" title="Warrants and rights outstanding">89,760 cash commission) and issued <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20251030__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQJFEnRFzyUd" title="Sale of stock">22,770,002 shares of Common Stock (after <span id="xdx_901_ecustom--BonusShares_pid_c20251030__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8DhpFStB88j" title="Bonus shares">1,686,667 bonus shares), as well as <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251030__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIbGZlHWAa9f" title="Sale of stock">21,083,335 5-year warrants exercisable to buy Common Stock at $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9LlQkuvVjGi" title="Common stock price per shares">0.12 per share. The net received by the Company was $0.047 per unit. In the six months ended on June 30, 2026, the company raised net cash proceeds of $314,640 (after payment of $27,360 in commission) the fair value of the Common Stock was determined based on the quoted market price of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zA6SS46Vjylg" title="Share price">0.031 per unit on the issuance date. The fair value of the warrants was estimated using the Black-Scholes option-pricing model, resulting in a fair value of $<span id="xdx_90A_eus-gaap--SaleOfStockPricePerShare_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeRxU2wgnAs5" title="Share price">0.016 per warrant, which differs from allocated purchase price. In accordance with ASC 505-10-30-6 (Relative Fair Value Allocation), the total proceeds were allocated to the Common Stock and the warrants based on their relative fair values on the date of issuance. The allocation was calculated as follows: SCHEDULE OF ALLOCATION OF FAIR VALUE IN PRIVATE PLACEMENT <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Component</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Standalone Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Total Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Allocation of Proceeds</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Allocation per Share/Warrant</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Common Stock (6,156,001 shares)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--FairValueOfCommonStock_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zq2jnfu50H8d" style="text-align: right" title="Fair value of common stock">340,245</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--FairValueOfCommonStockPercenatge_iI_pid_dp_uPure_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zP5y3mezHaz" title="% of Total Fair Value of warrants common stock">60.66</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z72ozMk0TZBd" style="text-align: right" title="Allocation of proceeds common stock">190,867</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.0310</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Common Stock (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFMTE9DQVRJT04gT0YgRkFJUiBWQUxVRSBJTiBQUklWQVRFIFBMQUNFTUVOVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFf8Nc8ysth8" title="Number of shares issued">6,156,001 shares)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--FairValueOfCommonStock_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zJTaIQU6hLJ6" style="width: 10%; text-align: right" title="Fair value of common stock">340,245</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90B_ecustom--FairValueOfCommonStockPercenatge_iI_pid_dp_uPure_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zDLFZ3qFhi9h" title="% of Total Fair Value of warrants common stock">60.66</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zvK7QA8zt0F4" style="width: 10%; text-align: right" title="Allocation of proceeds common stock">190,867</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.0310</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFMTE9DQVRJT04gT0YgRkFJUiBWQUxVRSBJTiBQUklWQVRFIFBMQUNFTUVOVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zh9Riwb5eXuf" title="Warrants">5,700,001 warrants)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--FairValueOfWarrants_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zwT3W3vy8fZf" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of warrants">220,643</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--FairValueOfWarrantsPercenatge_iI_pid_dp_uPure_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zf5LA0Ofqb2c" title="% of Total Fair Value of warrants">39.34</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ProceedsFromIssuanceOfWarrants_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIPP3KydDxmg" style="border-bottom: Black 1pt solid; text-align: right" title="Allocation of proceeds warrants">123,773</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zwGMjiATlbId" title="Allocation per Share/Warrant">0.0217</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Total</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_981_ecustom--StandaloneFairValue_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zfV7YP8krRWk" style="font-weight: bold; text-align: right" title="Standalone fair value">560,888</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">100</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--ProceedsFromOtherEquity_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zX4PK1rxwuQ6" style="font-weight: bold; text-align: right" title="Allocation of proceeds">314,640</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> The allocated value per share is $0.031 ($190,867 ÷ 6,156,001 shares), and the allocated value per warrant is $0.022 ($123,773 ÷ 5,700,001 warrants), or a 48.58% discount to market. When a company issues two or more equity instruments (e.g., Common Stock and warrants) in a single transaction for a lump-sum amount, the proceeds must be allocated to each instrument based on their relative fair values on the issuance date. No gain or loss is recognized on the initial recognition. Warrant Terms The warrants have an exercise price of $0.12 per share, are exercisable immediately, and expire between 10/25/2030 and 5/08/2031. Each warrant entitles the holder to purchase one share of Common Stock. As of June 30, 2026, 21,083,335 warrants were issued in connection with this offering. In accordance with ASC 505-10-50-3, the following information is disclosed regarding the warrants in the first six months of 2026: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Number of shares issuable upon exercise: 5,700,001 shares</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Exercise price: $0.12 per share</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Exercise period: through 5/08/2031</td></tr> </table> Fair Value Measurement (ASC 820) <p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zmaTuZo0OK36" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The fair value of the warrants was estimated using the Black-Scholes option-pricing model in accordance with ASC 820-10-35-2 (Fair Value Measurement Framework). The following significant inputs were used in the valuation: SCHEDULE OF SIGNIFICANT INPUTS OF FAIR VALUE MEASUREMENT <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Assumption</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Value</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify">Expected volatility</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zlqv2Q85UEl2" title="Warrants, measurement input">119.99%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Expected term</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5 years</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Risk-free interest rate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zVMeSMH6cNwh" title="Warrants, measurement input">3.92%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Expected dividend yield</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dn_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zqKZ3FE2lc3k" title="Warrants, measurement input">none</td></tr> </table> The fair value measurement of the warrants is classified within Level 3 of the fair value hierarchy established by ASC 820-10-35-37 through ASC 820-10-35-54A, as the valuation inputs include unobservable inputs (expected volatility) that are significant to the overall measurement. Warrant Activity <p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6ymqQ6IZFH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">A summary of warrant activity for the quarter ended June 30, 2026 is as follows: SUMMARY OF WARRANT ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants *</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Expected Term</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Outstanding as at January 1, 2026</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zU7DBtMRNHC7" style="width: 12%; font-weight: bold; text-align: right" title="Number of Warrants Outstanding, beginning of year">16,675,364</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingExercisePriceRageNumberOfShare_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRWfPUjrGuue" style="width: 12%; font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Outstanding, beginning of year">0.13</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcMmY3zJwMDb" style="width: 12%; font-weight: bold; text-align: right" title="Weighted average remaining expected term, outstanding">4.6</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zP0yIcX43aK5" style="text-align: right" title="Number of Warrants, Granted">5,700,001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriodExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFncfDNtYVBe" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.12</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVpqdnlCXjR1" style="text-align: right" title="Weighted average remaining expected term, granted">5.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMUZAYOxunV8" style="text-align: right" title="Number of Warrants, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedInPeriodExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVoqAzLPKn4i" style="text-align: right" title="Weighted Average Exercise Price, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Forfeited/Cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWSqw3onSKP6" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Forfeited/Cancelled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionForfeitedOrExpiredInPeriodExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zqFr6cJN1hs1" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Outstanding as at June 30, 2026</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhXrD8b8q2v4" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Number of Warrants Outstanding, end of year">22,375,365</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingExercisePriceRageNumberOfShare_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlWbD1GfnHm9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Outstanding, end of year">0.12</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zX8mSIVxpSkd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Weighted average remaining expected term, outstanding">4.6</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

0.051

1032240

89760

22770002

1686667

21083335

0.12

0.047

314640

27360

0.031

0.016

The allocation was calculated as follows: SCHEDULE OF ALLOCATION OF FAIR VALUE IN PRIVATE PLACEMENT <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Component</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Standalone Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Total Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Allocation of Proceeds</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Allocation per Share/Warrant</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Common Stock (6,156,001 shares)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--FairValueOfCommonStock_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zq2jnfu50H8d" style="text-align: right" title="Fair value of common stock">340,245</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--FairValueOfCommonStockPercenatge_iI_pid_dp_uPure_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zP5y3mezHaz" title="% of Total Fair Value of warrants common stock">60.66</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z72ozMk0TZBd" style="text-align: right" title="Allocation of proceeds common stock">190,867</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.0310</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Common Stock (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFMTE9DQVRJT04gT0YgRkFJUiBWQUxVRSBJTiBQUklWQVRFIFBMQUNFTUVOVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFf8Nc8ysth8" title="Number of shares issued">6,156,001 shares)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--FairValueOfCommonStock_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zJTaIQU6hLJ6" style="width: 10%; text-align: right" title="Fair value of common stock">340,245</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90B_ecustom--FairValueOfCommonStockPercenatge_iI_pid_dp_uPure_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zDLFZ3qFhi9h" title="% of Total Fair Value of warrants common stock">60.66</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zvK7QA8zt0F4" style="width: 10%; text-align: right" title="Allocation of proceeds common stock">190,867</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.0310</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFMTE9DQVRJT04gT0YgRkFJUiBWQUxVRSBJTiBQUklWQVRFIFBMQUNFTUVOVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zh9Riwb5eXuf" title="Warrants">5,700,001 warrants)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--FairValueOfWarrants_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zwT3W3vy8fZf" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of warrants">220,643</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--FairValueOfWarrantsPercenatge_iI_pid_dp_uPure_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zf5LA0Ofqb2c" title="% of Total Fair Value of warrants">39.34</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ProceedsFromIssuanceOfWarrants_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIPP3KydDxmg" style="border-bottom: Black 1pt solid; text-align: right" title="Allocation of proceeds warrants">123,773</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zwGMjiATlbId" title="Allocation per Share/Warrant">0.0217</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Total</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_981_ecustom--StandaloneFairValue_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zfV7YP8krRWk" style="font-weight: bold; text-align: right" title="Standalone fair value">560,888</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">100</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--ProceedsFromOtherEquity_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zX4PK1rxwuQ6" style="font-weight: bold; text-align: right" title="Allocation of proceeds">314,640</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> 340245 0.6066

190867

0.0310

6156001

340245 0.6066

190867

0.0310

5700001

220643 0.3934

123773

0.0217

560888 1

314640

The allocated value per share is $0.031 ($190,867 ÷ 6,156,001 shares), and the allocated value per warrant is $0.022 ($123,773 ÷ 5,700,001 warrants), or a 48.58% discount to market.

0.12

10/25/2030 and 5/08/2031

21083335

5700001

0.12

5/08/2031

<p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zmaTuZo0OK36" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The fair value of the warrants was estimated using the Black-Scholes option-pricing model in accordance with ASC 820-10-35-2 (Fair Value Measurement Framework). The following significant inputs were used in the valuation: SCHEDULE OF SIGNIFICANT INPUTS OF FAIR VALUE MEASUREMENT <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Assumption</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Value</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify">Expected volatility</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zlqv2Q85UEl2" title="Warrants, measurement input">119.99%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Expected term</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5 years</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Risk-free interest rate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zVMeSMH6cNwh" title="Warrants, measurement input">3.92%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Expected dividend yield</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dn_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zqKZ3FE2lc3k" title="Warrants, measurement input">none</td></tr> </table>

119.99

P5Y

3.92

<p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6ymqQ6IZFH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">A summary of warrant activity for the quarter ended June 30, 2026 is as follows: SUMMARY OF WARRANT ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants *</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Expected Term</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Outstanding as at January 1, 2026</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zU7DBtMRNHC7" style="width: 12%; font-weight: bold; text-align: right" title="Number of Warrants Outstanding, beginning of year">16,675,364</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingExercisePriceRageNumberOfShare_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRWfPUjrGuue" style="width: 12%; font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Outstanding, beginning of year">0.13</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcMmY3zJwMDb" style="width: 12%; font-weight: bold; text-align: right" title="Weighted average remaining expected term, outstanding">4.6</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zP0yIcX43aK5" style="text-align: right" title="Number of Warrants, Granted">5,700,001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriodExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFncfDNtYVBe" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.12</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVpqdnlCXjR1" style="text-align: right" title="Weighted average remaining expected term, granted">5.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMUZAYOxunV8" style="text-align: right" title="Number of Warrants, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedInPeriodExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVoqAzLPKn4i" style="text-align: right" title="Weighted Average Exercise Price, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Forfeited/Cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWSqw3onSKP6" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Forfeited/Cancelled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionForfeitedOrExpiredInPeriodExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zqFr6cJN1hs1" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Outstanding as at June 30, 2026</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhXrD8b8q2v4" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Number of Warrants Outstanding, end of year">22,375,365</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingExercisePriceRageNumberOfShare_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlWbD1GfnHm9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Weighted Average Exercise Price, Outstanding, end of year">0.12</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zX8mSIVxpSkd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Weighted average remaining expected term, outstanding">4.6</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

16675364

0.13 P4Y7M6D

5700001

0.12 P5Y

22375365

0.12 P4Y7M6D

NOTE 11 – STOCKHOLDERS’ EQUITY Preferred stock The Company is authorized to issue 50,000,000 shares of Preferred Stock. Each share of Preferred Stock has the voting power of ten shares of Common Stock, and can at any time be converted into five (5), shares of Common Stock. The table below sets forth the number of shares of Preferred Stock issued and outstanding during the reporting period(s). There were 43,283,991 Preferred Stock outstanding on June 30, 2026: Issuances of Preferred Stock in the period January 1 and June 30, 2025 SCHEDULE OF PREFERRED STOCK ISSUED AND OUTSTANDING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">1/01/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center"> </td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250101__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_z45838OcCNr3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">43,158,248</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250101__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zXbd5lmb4s9l" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">4,408,582</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_984_eus-gaap--SharePrice_iI_c20250101__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zDTIN3IBKxPj" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.102</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/10/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">b</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_di_c20250110__20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zKZoRNShVCMh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">(150,000</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250110__20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zCzVBi5U2uo3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">(750</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_981_eus-gaap--SharePrice_iI_c20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zuVDmhWATZ6l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.005</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Stock conversion</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">3/31/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250331__20250331__us-gaap--SubsidiarySaleOfStockAxis__custom--PayrollForfeitureMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zhNY71pFp53f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">214,780</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Payroll forfeiture*</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: bottom">See Note 12</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">d</td> <td> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoThousandsTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zhJnhT9l1ur3" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Shares">421,391</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoThousandsTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zK15BdiHzdE2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Amount">153,342</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td id="xdx_987_eus-gaap--SharePrice_iI_c20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoThousandsTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zGh8byam6Pxa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Share price">0.364</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">2021 Stock Plan</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">6/30/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zmfR3fmpWDBg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Shares">43,429,639</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">$</td> <td id="xdx_989_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zrBYjPJMObc7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Amount">4,774,544</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">$</td> <td id="xdx_98F_eus-gaap--SharePrice_iI_c20250630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zzLop30dqOsd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Price/Share">0.110</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td></tr> </table> There has been no issuance of Preferred Stock in the period January 1 and June 30, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">6/30/2026</td> <td style="width: 4%"> </td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zLdJ6FEIZrRl" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">43,283,991</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zD1SDfIKrof4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">4,748,150</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98B_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zLnBhOuQoztl" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Price/Share">0.110</td> <td style="width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="width: 1%"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">*</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">The transaction originating from the Company’s Officers forfeiting $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBSRUZFUlJFRCBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--AccruedPayrollTaxesCurrentAndNoncurrent_iI_c20250331_zSK5yUMjqqJ8" title="Accrued payroll">578,959 of accrued payroll in the first quarter of 2025.</td></tr> </table> Common stock The Company is authorized to issue 400,000,000 shares of Common Stock. There were 114,695,219 Common Stock outstanding on June 30, 2026: Issuances of Common Stock in the period January 1 and June 30, 2025 SCHEDULE OF COMMON STOCK ISSUED AND OUTSTANDING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">1/01/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"> </td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_zFQW9LhqKCTj" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">86,782,908</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_zPa283TMOHw7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">12,722,039</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98F_eus-gaap--SharePrice_iI_c20250101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_z0YmBsIFcMlk" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.147</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%"> </td> <td style="width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/10/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">d</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250110__20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember_fZA_____zLSoNQYDW8xi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">750,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250110__20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember_fZA_____zbBkvLZHloa7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">750</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--SharePrice_iI_c20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember_fZA_____z2MMQfMDbnC3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Stock conversion</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">see Note 12</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">d</td> <td> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250101__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--StockPlanTwoThousandsTwentyOneMember_fZA_____zks6UaIZSVme" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">1,409,335</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20250101__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--StockPlanTwoThousandsTwentyOneMember_fZA_____zh3KfhUvgkqi" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">106,754</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_eus-gaap--SharePrice_iI_c20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--StockPlanTwoThousandsTwentyOneMember_fZA_____ztoQzUaQl21d" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.073</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">2021 Stock Plan</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">b</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_fYg_____za46s0RrBmec" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">88,942,243</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_fYg_____zy0N24OFHP6k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">12,829,543</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_982_eus-gaap--SharePrice_iI_c20250630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_fYg_____zVhnNTJ18NXg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.144</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td></tr> </table> Issuances of Common Stock in the period January 1 and June 30, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">1/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_fKDQp_z2XtxL7yDtk6" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">108,147,731</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_zXfRZQUIPjP1" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">13,607,433</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_985_eus-gaap--SharePrice_iI_c20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_zvlnelxnLVm1" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.126</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/23/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">*</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260123__20260123__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSAq_zyoGy7gnMaa9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">4,716,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260123__20260123__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSAq_zOX5fZcOHjH8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">145,701</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--SharePrice_iI_c20260123__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSAq_zUvlchlMRuxf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.031</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">private placement</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/23/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">*</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260123__20260123__us-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsMember_fYSAq_zeKUgKAKvfSk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260123__20260123__us-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsMember_fYSAq_zizFSFdDzSf8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">95,339</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_980_eus-gaap--SharePrice_iI_c20260123__us-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsMember_fYSAq_zSFz8m61JNb7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/10/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">c</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260110__20260110__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zoSwoNGygys6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">75,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260110__20260110__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____za5pn01MsSQ6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">5,550</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--SharePrice_iI_c20260110__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zVwmLaK6RiNe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.074</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fees</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">2/10/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">c</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260210__20260210__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zpOOdTEu0Ct9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">239,155</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260210__20260210__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zePTHxzQwnp7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">10,723</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_982_eus-gaap--SharePrice_iI_c20260210__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zTU23MTCbUpl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.046</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fees</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">3/10/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">c</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260310__20260310__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zPO6Jy9UYxd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">184,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260310__20260310__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zjcmGZLdRsvj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">8,150</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_987_eus-gaap--SharePrice_iI_c20260310__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zxhucpXxaNH9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.044</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fees</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">5/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">†</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260508__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSCG_zaEfgHO9xemd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">1,333,334</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260508__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSCG_zgFr0DKyoZG5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">45,453</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_989_eus-gaap--SharePrice_iI_c20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSCG_z0h6EfZR3wF6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.040</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">private placement</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">5/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">†</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260508__20260508__us-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsMember_fYSCG_zFZ2jF6J7Hh6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">28,147 </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--SharePrice_iI_c20260508__us-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsMember_fYSCG_zP1dJkEGcbxl" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">6/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_z19smgToqVdb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">114,695,220</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_zcINFFzyGuD" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">13,946,496</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_984_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_znpRCmllsZxb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.122</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> Common Shares due, but not yet issued in accordance with service contract at June 30, 2026: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 14%">1/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zXkv15NUJLmj" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">75,000</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zgMCnauWZGBb" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">4,883</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_989_eus-gaap--SharePrice_iI_c20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zZExlo1nKN6c" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.065</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%">consulting fees</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">5/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">†</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--CommisionMember_fYSCG_zZ5EDDCwIWg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">106,667</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--CommisionMember_fYSCG_zj5Mt5GfFUv1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--SharePrice_iI_c20260508__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--CommisionMember_fYSCG_zGIFvezD536d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">commission</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">6/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260630__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zF9uPpqJnXle" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">661,770</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260630__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zIPPDgplSeyj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">22,593</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_983_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zk8jGBxMmjT" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.034</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fees</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">6/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260630__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember_zduLfpzZoW64" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">843,437</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260630__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember_z6m8LIJc843a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">27,476</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98A_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember_zrEgHZWJhd77" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.033</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">*</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">Around January 23, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20260123_zuPp79LM7Qkh" title="Common stock, par value">0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised a total of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--PaymentsForRepurchaseOfPrivatePlacement_c20260123__20260123__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zsd7UyWURAi7" title="Private placement offering">241,040 (after $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--PaymentsForCommissions_c20260123__20260123_zGNQCCmsXRv6" title="Broker commission">20,960 cash commission) and issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20260123_zUffIHkQkdzf" title="Common stock, shares issued">4,716,000 shares of Common Stock (after <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--BonusShares_c20260123__20260123__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zz8VfxdRJmc" title="Bonus shares">349,333 bonus shares), as well as <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_pid_c20260123__20260123__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbUn8ipIx2Nk" title="Warrants outstanding, number of warrants">4,366,667 <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260123__20260123__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrlrmGxBpaic" title="Weighted average remaining contractual term, Ending balance">5-year warrants exercisable to buy Common Stock at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iI_pid_c20260123__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgLg2lXelSOa" title="Weighted average exercise price">0.12 per share. The net received by the Company was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--SharePrice_iI_pid_c20260123__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8IcuUX4B7j9" title="Shares issued, price per share">0.053 per unit.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">†</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">Around May 8, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20260508_zyRwzJqU5ozd" title="Common stock, par value">0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised a total of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20260508__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zYl1tGEHPzhb" title="Private placement offering">73,600 (after $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--CashCommission_c20260508__20260508_zKcVltm2LQ6f" title="Cash commission">6,400 cash commission) and issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_pid_c20260508_zHuDnRlXwmR1" title="Common stock, shares issued">1,440,001 shares of Common Stock (after <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--BonusShares_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrpfNS3dLRb5" title="Bonus shares">106,667 bonus shares), as well as <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_pid_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5paJ6lvMrvf" title="Warrants outstanding, number of warrants">1,333,334 <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zyUDktWv6b85" title="Weighted average remaining contractual term, Ending balance">5-year warrants exercisable to buy Common Stock at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iI_c20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zb03tpmP59ka" title="Weighted average exercise price">0.12 per share. The net received by the Company was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--SharePrice_iI_pid_c20260508__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8ysOY0DbF5b" title="Shares issued, price per share">0.053 per unit.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">a</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">b</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act pursuant to the exchange exemption under Rule 144 of the Securities Act.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">c</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act pursuant to the exchange exemption in Rule 3(a)(9) of the Securities Act.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">d</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to Rule 701 of the Securities Act.</td></tr> </table> Common Stock Warrants <p id="xdx_89B_ecustom--ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock_zmHgXh2ry2Ij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The fair value of Common Stock warrants granted for the six months ended June 30, 2026, and June 30, 2025 was calculated with the following assumptions: SCHEDULE OF STOCK WARRANTS VALUATION ASSUMPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_492_20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHzwFjNjiFFe" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2026</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_493_20250101__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsWxAQPOOqAh" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2025</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%">Risk-free interest rate</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zTQfWuF2TChc" title="Risk-free interest rate">3.92 – <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zYUnn9ihUdLi" title="Risk-free interest rate">4.02</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">%</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zu45eX172Qij" title="Risk-free interest rate">3.96 – <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zVePTrgBf4zj" title="Risk-free interest rate">4.61</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">%</td></tr> <tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_zxWdqSLnMmS" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Expected dividend yield</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_zv5TqilNuf5l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Volatility factor (monthly)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">118.17</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">127.02</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Expected life of warrant</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWJ4uxnwbjt8" title="Expected life of warrant">5 years</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdOUEl2c3Fk7" title="Expected life of warrant">5 years</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> For the six months ended June 30, 2026, the Company issued <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zUYPSuWBBTAh" title="Warrants outstanding, number of warrants">5,700,001 warrants. For the six months ended June 30, 2025, the Company did not award any warrants. <p id="xdx_899_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdUmhbYGgMs9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The following table summarizes the Company’s Common Stock warrant activity for the six months ended June 30, 2026, and 2025: SCHEDULE OF COMMON STOCK WARRANT ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants *</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Expected Term</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 51%">Outstanding as at January 1, 2025</td><td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250101__20250630_zgnfERi8KRM" style="width: 12%; text-align: right" title="Number of Warrants Oustanding, Balance">1,292,030</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20250101__20250630_z7sYgUV1NLE3" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Balance">0.22</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20250630_zxJYaZ3wMZk9" title="Weighted average remaining contractual term, Beginning balance">2.6</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20250101__20250630_zvORkIBdviH7" style="text-align: right" title="Number of Warrants, Granted">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_c20250101__20250630_zCkhYFLsbFHg" style="text-align: right" title="Weighted Average Exercise Price, Granted">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20250101__20250630_zyyhKT8Ec7Dh" style="text-align: right" title="Number of Warrants, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_c20250101__20250630_zyqbTMOkE4i9" style="text-align: right" title="Weighted Average Exercise Price, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Forfeited/Cancelled</td><td style="padding-bottom: 1pt"> </td> <td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_c20250101__20250630_z4dZIAoXYgvf" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Forfeited/Cancelled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20250101__20250630_zXypZVGaN2oi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited/Canceled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding as at June 30, 2025</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20250101__20250630_zzUK0YfzBMEk" style="text-align: right" title="Number of Warrants Oustanding, Balance">1,292,030</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20250101__20250630_zKZOufTorOOk" style="text-align: right" title="Weighted Average Exercise Price, Balance">0.22</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20250101__20250630_z9PCgAhPmCGg" title="Weighted average remaining contractual term, Ending balance">2.7</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding as at January 1, 2026</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260630_z22CpjrLkjYh" style="text-align: right" title="Number of Warrants Oustanding, Balance">16,675,364</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260630_zDKWF10XV6Jk" style="text-align: right" title="Weighted Average Exercise Price, Balance">0.13</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630_z6ZMF2G1CS99" title="Weighted average remaining contractual term, Beginning balance">4.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260630_zoJsufRvMTg5" style="text-align: right" title="Number of Warrants, Granted">5,700,001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260630_zsR2cUGy8u9a" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.12</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20260101__20260630_zViJnTFXkldj" title="Weighted- Average Remaining Expected Term, Granted">5.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260630_zCY7ykbqGJC" style="text-align: right" title="Number of Warrants, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_c20260101__20260630_zbtE07h0YTW7" style="text-align: right" title="Weighted Average Exercise Price, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Forfeited/Cancelled</td><td style="padding-bottom: 1pt"> </td> <td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_c20260101__20260630_zAnfD3saRoKl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Forfeited/Cancelled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20260101__20260630_zi3fc57qnShl" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited/Canceled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding as at June 30, 2026</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260630_zKeXS2RHsdvd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Number of Warrants Oustanding, Balance">22,375,365</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260630_z9I8p7K126xb" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Balance">0.13</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260101__20260630_zrf5JMAp6m03" title="Weighted average remaining contractual term, Ending balance">4.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The following table summarizes information about stock warrants that are vested or expected to vest at June 30, 2026, with a market price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNUT0NLSE9MREVSU5IgRVFVSVRZIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260630_zTEm0w7EI8B6" title="Weighted average exercise price">0.045 at June 30, 2026: SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Warrants Outstanding and Exercisable</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Number of Warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Weighted Average Exercise Price Per Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Weighted Average Remaining Contractual Life (Years)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Aggregate Intrinsic Value</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: right"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zTwMDp8dqrjk" title="Warrants Outstanding, Exercise Price">0.12</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zrIfSxjSKHUc" style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: right" title="Warrants Outstanding, Number of Warrants">21,083,335</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_z9nlMa5dmIBh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Warrants Outstanding, Weighted Average Exercise Price Per Share">0.12</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zsrFDfWQZEjd" title="Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)">4.7</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zn4dz215A7Z9" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Warrants Outstanding, Aggregate Intrinsic Value">—</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__srt--RangeAxis__srt--MinimumMember_zKhhbwXEW0dg" title="Warrants Outstanding, Exercise Price">0.20-<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__srt--RangeAxis__srt--MaximumMember_zwdKYYxlVr2i" title="Warrants Outstanding, Exercise Price">0.25</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_z3odcPonXLC5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Number of Warrants">1,264,030</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zup3ukAhD7il" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Weighted Average Exercise Price Per Share">0.23</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zYULLboF5e75" title="Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)">1.7</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zvsBBBsvRck2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Aggregate Intrinsic Value">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zJvW49Jfafq4" title="Warrants Outstanding, Exercise Price">0.47</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zUSA7cYh9VWl" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Number of Warrants">28,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zkFQNOou9UR1" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Weighted Average Exercise Price Per Share">0.47</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zoTGQPXbIVJj" title="Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)">1.4</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zJbHIKr0rIYa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Aggregate Intrinsic Value">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z5iE72k8HZ46" title="Warrants Outstanding, Exercise Price">0.12-<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zoUhXEOVd5j2" title="Warrants Outstanding, Exercise Price">0.47</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhsJGaGDL7a4" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Number of Warrants">22,375,365</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6O1vEoJ1CAj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Weighted Average Exercise Price Per Share">0.13</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcmycoknOld9" title="Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)">4.3</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5AROMaN7jia" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Aggregate Intrinsic Value">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> The weighted-average remaining contractual life for warrants exercisable at June 30, 2026, is <span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdWyVnXmRXA7" title="Warrants exercisable, weighted average remaining contractual life">4.2 years. The aggregate intrinsic value for fully vested, exercisable warrants was $<span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_dxL_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zV10HUxFpHG7" title="Warrants outstanding, aggregate intrinsic value::XDX::-">0 at June 30, 2026.

50000000

43283991

Issuances of Preferred Stock in the period January 1 and June 30, 2025 SCHEDULE OF PREFERRED STOCK ISSUED AND OUTSTANDING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">1/01/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center"> </td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250101__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_z45838OcCNr3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">43,158,248</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250101__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zXbd5lmb4s9l" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">4,408,582</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_984_eus-gaap--SharePrice_iI_c20250101__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zDTIN3IBKxPj" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.102</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/10/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">b</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_di_c20250110__20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zKZoRNShVCMh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">(150,000</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250110__20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zCzVBi5U2uo3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">(750</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_981_eus-gaap--SharePrice_iI_c20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zuVDmhWATZ6l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.005</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Stock conversion</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">3/31/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250331__20250331__us-gaap--SubsidiarySaleOfStockAxis__custom--PayrollForfeitureMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zhNY71pFp53f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">214,780</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Payroll forfeiture*</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: bottom">See Note 12</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">d</td> <td> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoThousandsTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zhJnhT9l1ur3" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Shares">421,391</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoThousandsTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zK15BdiHzdE2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Amount">153,342</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td id="xdx_987_eus-gaap--SharePrice_iI_c20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--TwoThousandsTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zGh8byam6Pxa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Share price">0.364</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">2021 Stock Plan</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">6/30/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zmfR3fmpWDBg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Shares">43,429,639</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">$</td> <td id="xdx_989_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zrBYjPJMObc7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Amount">4,774,544</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">$</td> <td id="xdx_98F_eus-gaap--SharePrice_iI_c20250630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zzLop30dqOsd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Price/Share">0.110</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td></tr> </table> There has been no issuance of Preferred Stock in the period January 1 and June 30, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">6/30/2026</td> <td style="width: 4%"> </td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zLdJ6FEIZrRl" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">43,283,991</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zD1SDfIKrof4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">4,748,150</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98B_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--PreferredStockIssuedAndOutstandingMember_zLnBhOuQoztl" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Price/Share">0.110</td> <td style="width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="width: 1%"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">*</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">The transaction originating from the Company’s Officers forfeiting $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBSRUZFUlJFRCBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--AccruedPayrollTaxesCurrentAndNoncurrent_iI_c20250331_zSK5yUMjqqJ8" title="Accrued payroll">578,959 of accrued payroll in the first quarter of 2025.</td></tr> </table>

43158248

4408582

0.102

150000

-750

0.005

214780

421391

153342

0.364

43429639

4774544

0.110

43283991

4748150

0.110

578959

400000000

114695219

Issuances of Common Stock in the period January 1 and June 30, 2025 SCHEDULE OF COMMON STOCK ISSUED AND OUTSTANDING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">1/01/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"> </td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_zFQW9LhqKCTj" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">86,782,908</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_zPa283TMOHw7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">12,722,039</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98F_eus-gaap--SharePrice_iI_c20250101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_z0YmBsIFcMlk" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.147</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%"> </td> <td style="width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/10/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">d</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250110__20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember_fZA_____zLSoNQYDW8xi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">750,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250110__20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember_fZA_____zbBkvLZHloa7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">750</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--SharePrice_iI_c20250110__us-gaap--SubsidiarySaleOfStockAxis__custom--StockConversionMember_fZA_____z2MMQfMDbnC3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Stock conversion</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">see Note 12</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">d</td> <td> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250101__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--StockPlanTwoThousandsTwentyOneMember_fZA_____zks6UaIZSVme" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">1,409,335</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20250101__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--StockPlanTwoThousandsTwentyOneMember_fZA_____zh3KfhUvgkqi" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">106,754</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_eus-gaap--SharePrice_iI_c20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--StockPlanTwoThousandsTwentyOneMember_fZA_____ztoQzUaQl21d" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.073</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">2021 Stock Plan</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">b</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_fYg_____za46s0RrBmec" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">88,942,243</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_fYg_____zy0N24OFHP6k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">12,829,543</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_982_eus-gaap--SharePrice_iI_c20250630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_fYg_____zVhnNTJ18NXg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.144</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td></tr> </table> Issuances of Common Stock in the period January 1 and June 30, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">1/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_fKDQp_z2XtxL7yDtk6" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">108,147,731</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_zXfRZQUIPjP1" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">13,607,433</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_985_eus-gaap--SharePrice_iI_c20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_zvlnelxnLVm1" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.126</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/23/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">*</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260123__20260123__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSAq_zyoGy7gnMaa9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">4,716,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260123__20260123__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSAq_zOX5fZcOHjH8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">145,701</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--SharePrice_iI_c20260123__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSAq_zUvlchlMRuxf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.031</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">private placement</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/23/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">*</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260123__20260123__us-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsMember_fYSAq_zeKUgKAKvfSk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260123__20260123__us-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsMember_fYSAq_zizFSFdDzSf8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">95,339</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_980_eus-gaap--SharePrice_iI_c20260123__us-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsMember_fYSAq_zSFz8m61JNb7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/10/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">c</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260110__20260110__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zoSwoNGygys6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">75,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260110__20260110__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____za5pn01MsSQ6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">5,550</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--SharePrice_iI_c20260110__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zVwmLaK6RiNe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.074</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fees</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">2/10/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">c</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260210__20260210__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zpOOdTEu0Ct9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">239,155</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260210__20260210__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zePTHxzQwnp7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">10,723</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_982_eus-gaap--SharePrice_iI_c20260210__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zTU23MTCbUpl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.046</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fees</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">3/10/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">c</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260310__20260310__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zPO6Jy9UYxd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">184,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260310__20260310__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zjcmGZLdRsvj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">8,150</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_987_eus-gaap--SharePrice_iI_c20260310__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYw_____zxhucpXxaNH9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.044</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fees</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">5/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">†</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260508__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSCG_zaEfgHO9xemd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">1,333,334</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260508__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSCG_zgFr0DKyoZG5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">45,453</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_989_eus-gaap--SharePrice_iI_c20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_fYSCG_z0h6EfZR3wF6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.040</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">private placement</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">5/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">†</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260508__20260508__us-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsMember_fYSCG_zFZ2jF6J7Hh6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">28,147 </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--SharePrice_iI_c20260508__us-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsMember_fYSCG_zP1dJkEGcbxl" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">6/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_z19smgToqVdb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">114,695,220</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_zcINFFzyGuD" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">13,946,496</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_984_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedAndOutstandingMember_znpRCmllsZxb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.122</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> Common Shares due, but not yet issued in accordance with service contract at June 30, 2026: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 14%">1/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zXkv15NUJLmj" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">75,000</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zgMCnauWZGBb" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">4,883</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_989_eus-gaap--SharePrice_iI_c20260101__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zZExlo1nKN6c" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.065</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%">consulting fees</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">5/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">†</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--CommisionMember_fYSCG_zZ5EDDCwIWg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">106,667</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--CommisionMember_fYSCG_zj5Mt5GfFUv1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--SharePrice_iI_c20260508__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--CommisionMember_fYSCG_zGIFvezD536d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">commission</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">6/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260630__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zF9uPpqJnXle" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">661,770</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260630__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zIPPDgplSeyj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">22,593</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_983_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConsultingFeesMember_fYQ_____zk8jGBxMmjT" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.034</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fees</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">6/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260630__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember_zduLfpzZoW64" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">843,437</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260630__20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember_z6m8LIJc843a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">27,476</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98A_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuedMember_zrEgHZWJhd77" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.033</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">*</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">Around January 23, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20260123_zuPp79LM7Qkh" title="Common stock, par value">0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised a total of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--PaymentsForRepurchaseOfPrivatePlacement_c20260123__20260123__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zsd7UyWURAi7" title="Private placement offering">241,040 (after $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--PaymentsForCommissions_c20260123__20260123_zGNQCCmsXRv6" title="Broker commission">20,960 cash commission) and issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20260123_zUffIHkQkdzf" title="Common stock, shares issued">4,716,000 shares of Common Stock (after <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--BonusShares_c20260123__20260123__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zz8VfxdRJmc" title="Bonus shares">349,333 bonus shares), as well as <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_pid_c20260123__20260123__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbUn8ipIx2Nk" title="Warrants outstanding, number of warrants">4,366,667 <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260123__20260123__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrlrmGxBpaic" title="Weighted average remaining contractual term, Ending balance">5-year warrants exercisable to buy Common Stock at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iI_pid_c20260123__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgLg2lXelSOa" title="Weighted average exercise price">0.12 per share. The net received by the Company was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--SharePrice_iI_pid_c20260123__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8IcuUX4B7j9" title="Shares issued, price per share">0.053 per unit.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">†</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">Around May 8, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20260508_zyRwzJqU5ozd" title="Common stock, par value">0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised a total of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20260508__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zYl1tGEHPzhb" title="Private placement offering">73,600 (after $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--CashCommission_c20260508__20260508_zKcVltm2LQ6f" title="Cash commission">6,400 cash commission) and issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_pid_c20260508_zHuDnRlXwmR1" title="Common stock, shares issued">1,440,001 shares of Common Stock (after <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--BonusShares_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrpfNS3dLRb5" title="Bonus shares">106,667 bonus shares), as well as <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_pid_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5paJ6lvMrvf" title="Warrants outstanding, number of warrants">1,333,334 <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zyUDktWv6b85" title="Weighted average remaining contractual term, Ending balance">5-year warrants exercisable to buy Common Stock at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iI_c20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zb03tpmP59ka" title="Weighted average exercise price">0.12 per share. The net received by the Company was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTU1PTiBTVE9DSyBJU1NVRUQgQU5EIE9VVFNUQU5ESU5HIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--SharePrice_iI_pid_c20260508__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8ysOY0DbF5b" title="Shares issued, price per share">0.053 per unit.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">a</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">b</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act pursuant to the exchange exemption under Rule 144 of the Securities Act.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">c</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act pursuant to the exchange exemption in Rule 3(a)(9) of the Securities Act.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">d</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to Rule 701 of the Securities Act.</td></tr> </table>

86782908

12722039

0.147

750000

750

0.001

1409335

106754

0.073

88942243

12829543

0.144

108147731

13607433

0.126

4716000

145701

0.031

95339

75000

5550

0.074

239155

10723

0.046

184000

8150

0.044

1333334

45453

0.040

28147

114695220

13946496

0.122

75000

4883

0.065

106667

661770

22593

0.034

843437

27476

0.033

0.06

241040

20960

4716000

349333

4366667

P5Y 0.12

0.053

0.06

73600

6400

1440001

106667

1333334

P5Y 0.12

0.053

<p id="xdx_89B_ecustom--ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock_zmHgXh2ry2Ij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The fair value of Common Stock warrants granted for the six months ended June 30, 2026, and June 30, 2025 was calculated with the following assumptions: SCHEDULE OF STOCK WARRANTS VALUATION ASSUMPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_492_20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHzwFjNjiFFe" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2026</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_493_20250101__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsWxAQPOOqAh" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2025</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%">Risk-free interest rate</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zTQfWuF2TChc" title="Risk-free interest rate">3.92 – <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zYUnn9ihUdLi" title="Risk-free interest rate">4.02</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">%</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zu45eX172Qij" title="Risk-free interest rate">3.96 – <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zVePTrgBf4zj" title="Risk-free interest rate">4.61</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">%</td></tr> <tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_zxWdqSLnMmS" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Expected dividend yield</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr id="xdx_40E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_zv5TqilNuf5l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Volatility factor (monthly)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">118.17</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">127.02</td> <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Expected life of warrant</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWJ4uxnwbjt8" title="Expected life of warrant">5 years</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdOUEl2c3Fk7" title="Expected life of warrant">5 years</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table>

0.0392

0.0402

0.0396

0.0461

1.1817

1.2702

P5Y

5700001

<p id="xdx_899_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdUmhbYGgMs9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The following table summarizes the Company’s Common Stock warrant activity for the six months ended June 30, 2026, and 2025: SCHEDULE OF COMMON STOCK WARRANT ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants *</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Expected Term</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 51%">Outstanding as at January 1, 2025</td><td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20250101__20250630_zgnfERi8KRM" style="width: 12%; text-align: right" title="Number of Warrants Oustanding, Balance">1,292,030</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20250101__20250630_z7sYgUV1NLE3" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Balance">0.22</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20250630_zxJYaZ3wMZk9" title="Weighted average remaining contractual term, Beginning balance">2.6</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20250101__20250630_zvORkIBdviH7" style="text-align: right" title="Number of Warrants, Granted">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_c20250101__20250630_zCkhYFLsbFHg" style="text-align: right" title="Weighted Average Exercise Price, Granted">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20250101__20250630_zyyhKT8Ec7Dh" style="text-align: right" title="Number of Warrants, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_c20250101__20250630_zyqbTMOkE4i9" style="text-align: right" title="Weighted Average Exercise Price, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Forfeited/Cancelled</td><td style="padding-bottom: 1pt"> </td> <td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_c20250101__20250630_z4dZIAoXYgvf" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Forfeited/Cancelled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20250101__20250630_zXypZVGaN2oi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited/Canceled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding as at June 30, 2025</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20250101__20250630_zzUK0YfzBMEk" style="text-align: right" title="Number of Warrants Oustanding, Balance">1,292,030</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20250101__20250630_zKZOufTorOOk" style="text-align: right" title="Weighted Average Exercise Price, Balance">0.22</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20250101__20250630_z9PCgAhPmCGg" title="Weighted average remaining contractual term, Ending balance">2.7</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding as at January 1, 2026</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260630_z22CpjrLkjYh" style="text-align: right" title="Number of Warrants Oustanding, Balance">16,675,364</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260630_zDKWF10XV6Jk" style="text-align: right" title="Weighted Average Exercise Price, Balance">0.13</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630_z6ZMF2G1CS99" title="Weighted average remaining contractual term, Beginning balance">4.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260630_zoJsufRvMTg5" style="text-align: right" title="Number of Warrants, Granted">5,700,001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260630_zsR2cUGy8u9a" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.12</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20260101__20260630_zViJnTFXkldj" title="Weighted- Average Remaining Expected Term, Granted">5.0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260630_zCY7ykbqGJC" style="text-align: right" title="Number of Warrants, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_c20260101__20260630_zbtE07h0YTW7" style="text-align: right" title="Weighted Average Exercise Price, Exercised">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Forfeited/Cancelled</td><td style="padding-bottom: 1pt"> </td> <td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_c20260101__20260630_zAnfD3saRoKl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants, Forfeited/Cancelled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20260101__20260630_zi3fc57qnShl" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited/Canceled">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding as at June 30, 2026</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260630_zKeXS2RHsdvd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Number of Warrants Oustanding, Balance">22,375,365</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260630_z9I8p7K126xb" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Balance">0.13</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260101__20260630_zrf5JMAp6m03" title="Weighted average remaining contractual term, Ending balance">4.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1292030

0.22 P2Y7M6D

1292030

0.22 P2Y8M12D

16675364

0.13 P4Y7M6D

5700001

0.12 P5Y

22375365

0.13 P4Y3M18D The following table summarizes information about stock warrants that are vested or expected to vest at June 30, 2026, with a market price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNUT0NLSE9MREVSU5IgRVFVSVRZIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20260630_zTEm0w7EI8B6" title="Weighted average exercise price">0.045 at June 30, 2026: SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Warrants Outstanding and Exercisable</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Number of Warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Weighted Average Exercise Price Per Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Weighted Average Remaining Contractual Life (Years)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Aggregate Intrinsic Value</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: right"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zTwMDp8dqrjk" title="Warrants Outstanding, Exercise Price">0.12</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zrIfSxjSKHUc" style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: right" title="Warrants Outstanding, Number of Warrants">21,083,335</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_z9nlMa5dmIBh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Warrants Outstanding, Weighted Average Exercise Price Per Share">0.12</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zsrFDfWQZEjd" title="Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)">4.7</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zn4dz215A7Z9" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Warrants Outstanding, Aggregate Intrinsic Value">—</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__srt--RangeAxis__srt--MinimumMember_zKhhbwXEW0dg" title="Warrants Outstanding, Exercise Price">0.20-<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember__srt--RangeAxis__srt--MaximumMember_zwdKYYxlVr2i" title="Warrants Outstanding, Exercise Price">0.25</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_z3odcPonXLC5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Number of Warrants">1,264,030</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zup3ukAhD7il" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Weighted Average Exercise Price Per Share">0.23</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zYULLboF5e75" title="Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)">1.7</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zvsBBBsvRck2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Aggregate Intrinsic Value">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zJvW49Jfafq4" title="Warrants Outstanding, Exercise Price">0.47</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zUSA7cYh9VWl" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Number of Warrants">28,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zkFQNOou9UR1" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Weighted Average Exercise Price Per Share">0.47</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zoTGQPXbIVJj" title="Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)">1.4</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zJbHIKr0rIYa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Aggregate Intrinsic Value">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z5iE72k8HZ46" title="Warrants Outstanding, Exercise Price">0.12-<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zoUhXEOVd5j2" title="Warrants Outstanding, Exercise Price">0.47</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhsJGaGDL7a4" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Number of Warrants">22,375,365</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6O1vEoJ1CAj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Weighted Average Exercise Price Per Share">0.13</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcmycoknOld9" title="Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)">4.3</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5AROMaN7jia" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Aggregate Intrinsic Value">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table>

0.045

0.12

21083335

0.12 P4Y8M12D

0.20

0.25

1264030

0.23 P1Y8M12D

0.47

28000

0.47 P1Y4M24D

0.12

0.47

22375365

0.13 P4Y3M18D P4Y2M12D

NOTE 12 – STOCK OPTION PLAN AND STOCK-BASED COMPENSATION On January 15, 2021, the Company adopted a stock option plan entitled “The 2021 Employee, Director and Consultant Stock Plan” (the “2021 Plan”) under which the Company may grant Options to Purchase Stock, Stock Awards or Stock Appreciation Rights up to <span id="xdx_909_ecustom--StockAwardsStockAppreciationRightsPercentage_pid_dp_uPure_c20210115__20210115__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zUb1TdntpGCe" title="Stock awards stock appreciation rights percentage">15% of the then fully diluted number of shares of the Company’s Common Stock, automatically adjusted on January 1 each year. On January 1, 2026, the 2021 Plan was reset in accordance with its stipulations. After the reset on January 1, 2026, there were <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20260101__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zBzMRao6tX9a" title="Stock awards available for grant">51,787,524 shares of Common Stock awards available for grant. Under the terms of the 2021 Plan, the Board of Directors shall specify the exercise price and vesting period of each stock option on the grant date. Vesting of the options is typically immediate and the options typically expire in five years. Stock Awards, which are fully and immediately vested upon issuance, may be directly issued under the Plan (without any intervening options). Shares Awarded and Issued 2021 Plan: As at June 30, 2026, there were <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_z2h9XHp5zYzh" title="Options outstanding number of shares">10,062,844 shares issued valued at a fair historic market value of $<span id="xdx_900_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_c20260101__20260630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zUeLJ5ER7aGe" title="Options granted, value">809,407 at the time of award and at June 30, 2025, there were <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20250630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zfqmQdk74WAh" title="Options outstanding number of shares">8,819,753 shares issued valued at a fair historic market value of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zZb8t7vKWedc" title="Options outstanding number of value">702,084 at the time of award. The following table summarizes the Company’s granted and issued stock awards in the six months ended June 30, 2026, and 2025: Issuances under the 2021 Stock Plan in the period January 1 and June 30, 2025 SCHEDULE OF GRANTED AND ISSUED STOCK AWARDS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">1/01/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250101__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_z1XFaIe0FTU" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">5,520,101</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250101__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zfx106RymURd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">481,057</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98F_eus-gaap--SharePrice_iI_c20250101__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zObaivg5u7tj" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.087</td> <td style="width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/06/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____z6HGq7uXRuHf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">634,921</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zXmciDwqkT92" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">43,045</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--SharePrice_iI_c20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zKJmDoDNw9ug" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.067</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/06/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zHXAO4P1Zy5g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">164,731</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zDT3C3MfuaYi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">11,037</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--SharePrice_iI_c20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zebKEAFxd3sg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.067</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/06/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zE70cPIiUKzj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">1,315,780</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zlfR4GZtXEZ1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">88,031</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_eus-gaap--SharePrice_iI_c20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zDrEkBrqAiGl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.067</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">bonus</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/06/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember_zVUw8aCIEwia" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">1,134,220</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember_z39p9DMyqvTi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">78,914</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--SharePrice_iI_c20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember_zMi0DftUkSk6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.067</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">bonus</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: bottom">5/12/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260512__20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zkLS1o23yz43" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Shares">156,255</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260512__20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zvWqqXbKLMlh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Amount">21,876</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_98A_eus-gaap--SharePrice_iI_c20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zyhbzvoDkYD3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Share price">0.140</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">affiliates</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: bottom">5/12/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260512__20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zZk40Fu6SQQ3" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Shares">110,384</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260512__20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zh9TGxuhOEA5" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Amount">15,454</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_98D_eus-gaap--SharePrice_iI_c20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zzWZ539EFes7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Share price">0.140</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">6/30/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zbLCmkF0exj6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">9,036,392</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zrkoqeHXNWF6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">739,889</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_984_eus-gaap--SharePrice_iI_c20250630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zhXmUd6EhcJ6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.081</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> There has been no issuance under the 2021 Stock Plan in the period January 1 and June 30, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">6/30/2026</td> <td style="width: 4%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zrQPzGM6EGz4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">10,062,844</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zaNGv0bzIrf" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">809,407</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98B_eus-gaap--SharePrice_iI_c20260630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zaiRe3vOWH8a" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Price/Share">0.080</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="width: 1%"> </td></tr> </table> Shares awarded, but not yet issued, under the 2021 Stock Plan at June 30, 2026: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 14%">1/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_fKg_____zmVPrzOTrZBh" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">1,081,875</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_fKg_____znBNEXzaKF45" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">82,006</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98E_eus-gaap--SharePrice_iI_c20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_fKg_____zNQKCCrR7r0l" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.076</td> <td style="width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zj9Rg8fKYrGf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">150,250</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_z3zcZs0PQ6Kb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">11,389</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_982_eus-gaap--SharePrice_iI_c20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_z5mAL5g3ZxAj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.076</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif">† </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260130__20260130__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PerformanceGrantMember_fKiCG_zvOj1f9UCOrj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">30,000,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260130__20260130__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PerformanceGrantMember_fKiCG_zHZ5naXcb9Se" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">1,278,600</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_981_eus-gaap--SharePrice_iI_c20260130__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PerformanceGrantMember_fKiCG_zvhn6diZPcP9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.043</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">performance grant</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">3/31/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260331__20260331__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_z4m9640VJ5U4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">254,240</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260331__20260331__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zIlKmtiIqvri" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">11,415</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98E_eus-gaap--SharePrice_iI_c20260331__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_z9RE6pWeJWjf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.045</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">6/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260630__20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zMvogdYZ8iQa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">300,568</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260630__20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zlez7OPUn5Of" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">7,815</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--SharePrice_iI_c20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_z9ghG0LRPgRe" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.026</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">6/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember_zxZCcdQvH5md" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">31,786,933</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember_zwduMrctfCv3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">1,391,225</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_987_eus-gaap--SharePrice_iI_c20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember_zwksdNRPAr7b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.044</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">The shares will be issued as shares of Preferred Stock, but are for comparison purposes expressed as Common share equivalents in this table.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center">†</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">The Board of Directors awarded the CEO <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdSQU5URUQgQU5EIElTU1VFRCBTVE9DSyBBV0FSRFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zSv1YtEzXGec" title="Preferred shares">6,000,000 Preferred Shares, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdSQU5URUQgQU5EIElTU1VFRCBTVE9DSyBBV0FSRFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zTSqhzx7riXa" title="Preferred stock, convertible, terms">a 1:5 conversion, as a performance grant in recognition for his role in advancing capital funding initiatives and establishing a distribution agreement for dietary supplements.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to Rule 701 of the Securities Act.</td></tr> </table> For the six months ended June 30, 2026, the Company recorded stock-based compensation expense of $1,297,830 ($1,278,600 to affiliates) in connection with share-based payment awards. For the six months ended June 30, 2025, the Company recorded stock-based compensation expense of $69,061 ($27,795 to affiliates) in connection with share-based payment awards. Stock options granted and vested 2021 Plan: As at June 30, 2026 and 2025, there was no unrecognized compensation expense related to non-vested stock option awards. As at June 30, 2026, the Company has <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20260630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zd5lmE1ZRs1d">20,000,591 options or stock awards available for grant under the 2021 Plan.

0.15

51787524

10062844

809407

8819753

702084

Issuances under the 2021 Stock Plan in the period January 1 and June 30, 2025 SCHEDULE OF GRANTED AND ISSUED STOCK AWARDS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">1/01/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250101__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_z1XFaIe0FTU" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">5,520,101</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250101__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zfx106RymURd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">481,057</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98F_eus-gaap--SharePrice_iI_c20250101__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zObaivg5u7tj" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.087</td> <td style="width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/06/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____z6HGq7uXRuHf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">634,921</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zXmciDwqkT92" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">43,045</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--SharePrice_iI_c20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zKJmDoDNw9ug" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.067</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/06/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zHXAO4P1Zy5g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">164,731</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zDT3C3MfuaYi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">11,037</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--SharePrice_iI_c20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zebKEAFxd3sg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.067</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/06/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zE70cPIiUKzj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">1,315,780</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zlfR4GZtXEZ1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">88,031</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_eus-gaap--SharePrice_iI_c20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_fKg_____zDrEkBrqAiGl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.067</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">bonus</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/06/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember_zVUw8aCIEwia" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">1,134,220</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250106__20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember_z39p9DMyqvTi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">78,914</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--SharePrice_iI_c20250106__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--BonusMember_zMi0DftUkSk6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.067</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">bonus</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: bottom">5/12/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260512__20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zkLS1o23yz43" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Shares">156,255</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260512__20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zvWqqXbKLMlh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Amount">21,876</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_98A_eus-gaap--SharePrice_iI_c20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember_zyhbzvoDkYD3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Share price">0.140</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">affiliates</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: bottom">5/12/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260512__20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zZk40Fu6SQQ3" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right" title="Shares">110,384</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260512__20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zh9TGxuhOEA5" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Amount">15,454</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td id="xdx_98D_eus-gaap--SharePrice_iI_c20260512__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zzWZ539EFes7" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Share price">0.140</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">6/30/2025</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zbLCmkF0exj6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">9,036,392</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20250630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zrkoqeHXNWF6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">739,889</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_984_eus-gaap--SharePrice_iI_c20250630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zhXmUd6EhcJ6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.081</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> There has been no issuance under the 2021 Stock Plan in the period January 1 and June 30, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">6/30/2026</td> <td style="width: 4%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zrQPzGM6EGz4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">10,062,844</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zaNGv0bzIrf" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">809,407</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98B_eus-gaap--SharePrice_iI_c20260630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneStockPlanMember_zaiRe3vOWH8a" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Price/Share">0.080</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="width: 1%"> </td></tr> </table> Shares awarded, but not yet issued, under the 2021 Stock Plan at June 30, 2026: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 14%">1/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_fKg_____zmVPrzOTrZBh" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">1,081,875</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_fKg_____znBNEXzaKF45" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">82,006</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98E_eus-gaap--SharePrice_iI_c20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_fKg_____zNQKCCrR7r0l" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Share price">0.076</td> <td style="width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zj9Rg8fKYrGf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">150,250</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_z3zcZs0PQ6Kb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">11,389</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_982_eus-gaap--SharePrice_iI_c20260101__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_z5mAL5g3ZxAj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.076</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">1/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif">† </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260130__20260130__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PerformanceGrantMember_fKiCG_zvOj1f9UCOrj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">30,000,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260130__20260130__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PerformanceGrantMember_fKiCG_zHZ5naXcb9Se" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">1,278,600</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_981_eus-gaap--SharePrice_iI_c20260130__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__srt--ConsolidatedEntitiesAxis__srt--AffiliatedEntityMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PerformanceGrantMember_fKiCG_zvhn6diZPcP9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.043</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">performance grant</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">3/31/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260331__20260331__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_z4m9640VJ5U4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">254,240</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260331__20260331__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zIlKmtiIqvri" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">11,415</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98E_eus-gaap--SharePrice_iI_c20260331__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_z9RE6pWeJWjf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.045</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">6/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260630__20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zMvogdYZ8iQa" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">300,568</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260630__20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_zlez7OPUn5Of" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">7,815</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--SharePrice_iI_c20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--StipendMember_z9ghG0LRPgRe" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share price">0.026</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">stipend</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">6/30/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260101__20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember_zxZCcdQvH5md" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">31,786,933</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260101__20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember_zwduMrctfCv3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">1,391,225</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_987_eus-gaap--SharePrice_iI_c20260630__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyOneStockPlanMember_zwksdNRPAr7b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.044</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">The shares will be issued as shares of Preferred Stock, but are for comparison purposes expressed as Common share equivalents in this table.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center">†</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">The Board of Directors awarded the CEO <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdSQU5URUQgQU5EIElTU1VFRCBTVE9DSyBBV0FSRFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zSv1YtEzXGec" title="Preferred shares">6,000,000 Preferred Shares, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdSQU5URUQgQU5EIElTU1VFRCBTVE9DSyBBV0FSRFMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zTSqhzx7riXa" title="Preferred stock, convertible, terms">a 1:5 conversion, as a performance grant in recognition for his role in advancing capital funding initiatives and establishing a distribution agreement for dietary supplements.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to Rule 701 of the Securities Act.</td></tr> </table>

5520101

481057

0.087

634921

43045

0.067

164731

11037

0.067

1315780

88031

0.067

1134220

78914

0.067

156255

21876

0.140

110384

15454

0.140

9036392

739889

0.081

10062844

809407

0.080

1081875

82006

0.076

150250

11389

0.076

30000000

1278600

0.043

254240

11415

0.045

300568

7815

0.026

31786933

1391225

0.044

6000000

a 1:5 conversion, as a performance grant in recognition for his role in advancing capital funding initiatives and establishing a distribution agreement for dietary supplements.

1297830

1278600

69061

27795

20000591

NOTE 13 – COMMITMENTS AND CONTINGENCIES Employment contracts Our Executive Officers have entered into employment contracts and confidentiality, non-disclosure and assignment of invention agreements. The most substantial provisions include; <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Compensation of three (3) times the employee’s annual salary upon the Termination Date and any target bonus earned, or if termination occurs within 12 months of a change in control, then the terminated employee shall receive two (2) times the employee’s annual salary and any target bonus earned.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Continued coverage under any health, medical, dental or vision program or policy, in which they were eligible to participate at the time of employment termination, for 12 months.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Provide outplacement services through one or more outside firms of the employee’s choosing up to an aggregate of $<span id="xdx_90F_eus-gaap--SupplementalUnemploymentBenefitsSeveranceBenefits_iI_c20260630__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember_zPgoXrPoQjy2" title="Payment of severance upon termination">50,000.</td></tr> </table> There are no other arrangements or plans in which we provide pension, retirement or similar benefits for any of Executive Officers or Directors. Litigation In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. Legal fees for such matters are expensed as incurred and we accrue for adverse outcomes as they become probable and estimable. On December 29, 2025, the Company terminated an officer for cause. The officer has contested all allegations and has, so far, submitted a worker rights complaint with the State of Washington Department of Labor and Industries (the “Department”), which the Company has contested as having no foundation or basis in fact. On April 30, 2026, the Company was informed that the Department had sided with the plaintive and on June 11, 2026, the Company was on informed that the initial appeal concerning the investigation by the Department had determined that the worker rights complaint filed by a former officer was justified and assessed the Balance of Wages, Interest & NSF Fee Due to $186,960.97 with an interest accrual of 1% per month. The Company made an additional appeal claiming that the Departments decision as having no foundation or basis in fact and strongly believe it will be successful in its claim. Never the less, the Company’s recorded reserves should cover the assessed amount and will not affect future results.

50000

186960.97

0.01

NOTE 14 – SUBSEQUENT EVENTS Unit Offering Subsequent to June 30, 2026, the Company raised net cash proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20260701__20260814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zelCQuTbFoPd" title="Proceeds from issuance of private placement">23,000 (after payment of $2,000 in commission) the fair value of the Common Stock was determined based on the quoted price of $<span id="xdx_904_eus-gaap--SharePrice_iI_pid_c20260814__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zeTFeXmG5ibb" title="Share price">0.051 per share on the issuance date. The fair value of the warrants was estimated using the Black-Scholes option-pricing model, resulting in a fair value of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260814__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zm0YAUlBf1Id" title="Warrant fair value">0.020 per warrant. In accordance with ASC 505-10-30-6 (Relative Fair Value Allocation), the total proceeds were allocated to the Common Stock and the warrants based on their relative fair values on the date of issuance. <p id="xdx_89E_ecustom--ScheduleOfAllocationOfFairValueInPrivatePlacementTableTextBlock_hus-gaap--AwardTypeAxis__custom--UnitOfferingMember_zlKhglbG7vAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The allocation was calculated as follows: SCHEDULE OF ALLOCATION OF FAIR VALUE IN PRIVATE PLACEMENT <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Component</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Standalone Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Total Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Allocation of Proceeds</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Allocation per Share/Warrant</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Common Stock (450,000 shares)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--FairValueOfCommonStock_iI_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqVwVXHWbQSb" style="text-align: right" title="Fair value of common stock">12,199</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--FairValueOfCommonStockPercenatge_iI_pid_dp_uPure_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7UPJgxqJCLh" title="% of Total Fair Value, Common stock">64.14</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8ZOTwIvtTdd" style="text-align: right" title="Allocation of Proceeds Common Stock">14,753</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMlmrwtV1M83" title="Share price">0.0328</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Common Stock (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFMTE9DQVRJT04gT0YgRkFJUiBWQUxVRSBJTiBQUklWQVRFIFBMQUNFTUVOVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z74gBUDTmzni" title="Number of shares issued">450,000 shares)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--FairValueOfCommonStock_iI_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zLf4Yj50qfd8" style="width: 12%; text-align: right" title="Fair value of common stock">12,199</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--FairValueOfCommonStockPercenatge_iI_pid_dp_uPure_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8rbB623ryba" title="% of Total Fair Value, Common stock">64.14</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zsWID7n0xKpi" style="width: 12%; text-align: right" title="Allocation of Proceeds Common Stock">14,753</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9P7OSWWNxw9" title="Share price">0.0328</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFMTE9DQVRJT04gT0YgRkFJUiBWQUxVRSBJTiBQUklWQVRFIFBMQUNFTUVOVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQE5xfDrkn1k" title="Number of shares issued">416,667 warrants)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--FairValueOfWarrants_iI_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvH64sUkzR51" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of warrants">6,819</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--FairValueOfWarrantsPercenatge_iI_pid_dp_uPure_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwFUjsIKnhh2" title="% of Total Fair Value, Warrants">35.86</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ProceedsFromIssuanceOfWarrants_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZEFTEn2OGCi" style="border-bottom: Black 1pt solid; text-align: right" title="Allocation of Proceeds Warrants">8,247</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zf048DnXM0Ri" title="Allocation per Share/Warrant">0.0198</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Total</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--StandaloneFairValue_iI_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3ZQI97sU0t3" style="text-align: right" title="Standalone fair value">19,017</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span id="xdx_909_ecustom--PercenatgeOfTotalFairValue_iI_pid_dp_uPure_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zFlCpmQivIm" title="% of Total Fair Value">100</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromOtherEquity_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyCsnW3yIDb1" style="font-weight: bold; text-align: right" title="Allocation of Proceeds">23,000</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> The allocated value per share is $0.033 ($14,753 ÷ 450,000 shares), and the allocated value per warrant is $0.020 ($8,247 ÷ 416,667 warrants), or a 20.9% premium to market. <p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_zHQoOh2hm9Be" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Shares earned/paid, but not yet issued, subsequent to June 30, 2026: SCHEDULE OF SHARES AWARDED <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">7/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center">b</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">† </td> <td style="width: 1%"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021Member__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYiCG_zZPybTI2KEnd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">31,081,875</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021Member__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYiCG_zmimaGWxuS94" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">1,360,606</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98B_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021Member__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYiCG_zjr0VvFoO1Tg" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Price/Share">0.044</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%">plan 2021</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">7/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">b</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021OneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYg_____zKuOA6LKYTje" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">705,058</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021OneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYg_____zFWehNhtdAh2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">30,619</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_983_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021OneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYg_____zLP4722EKggb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.043</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">plan 2021</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">7/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____z26n0lwTcece" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">736,770</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____za1PwnkRKKLk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">27,476</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zL4HRbi9U7ad" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.037</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fee</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">7/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--CommissionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zF2fpQ0RhQ1f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">106,667</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--CommissionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____znCSqOlUZ60e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--CommissionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____z78wXCsrnLE1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">commission</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">7/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">*</td> <td> </td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260708__20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_z6UUTqozyLO8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">450,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260708__20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zzHsBuiT0eml" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">14,753</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--SharePrice_iI_pid_c20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zJDBiQzoVYqg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.033</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">private placement</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">7/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">*</td> <td> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260708__20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PrivatePlacementOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zMNWOWWfMXz1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260708__20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PrivatePlacementOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zXYoiNmdeWOb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">8,247</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--SharePrice_iI_pid_c20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PrivatePlacementOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zg0rDU08mDe7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">private placement</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">7/05/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260705__20260705__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zGcA7HpZtS2b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">150,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_989_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260705__20260705__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zzl7QsJDKaHh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">3,750</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--SharePrice_iI_pid_c20260705__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____z4N46wiJ5abd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.025</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fee</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt">8/10/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260810__20260810__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeTwoMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zdFlAxh2Nyb3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">150,000</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260810__20260810__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeTwoMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zqsktgjCeAO1" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">3,300</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--SharePrice_iI_pid_c20260810__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeTwoMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zBgy87f01Sy2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.022</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">consulting fee</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">8/14/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260814__20260814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvD3OmbSMPHg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">33,380,370</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260814__20260814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgsSbna3zXrb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">1,448,751</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_989_eus-gaap--SharePrice_iI_pid_c20260814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zroutlTCrGU2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.043</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> Warrants paid, but not yet issued, subsequent to June 30, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Warrants</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">wavg Term</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">wavg Exerc</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">7/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">*</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: right"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20260708__20260708__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zzRk6ZXkb3Y4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Warrants Outstanding, Number of Warrants">416,667</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260708__20260708__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zZwu740f5YIb" title="Weighted average remaining contractual term, Ending balance">5.0</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iI_c20260708__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zUUuwlE5cWC1" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price">0.12</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td id="xdx_F08_zeqpqhBMIZI1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">During the period from April 20, 2026, to May 8, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zjdYbdCvuX0k" title="Market price">0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_ecustom--CashCommissionPercentage_pid_dp_c20260420__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zEiQp0QDFum8" title="Cash commission percentage">8% cash commission and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_ecustom--BonusSharesPercentage_pid_dp_c20260420__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5zJ7Is1owj5" title="Bonus shares percentage">8% bonus shares. The Company raised a total of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--PaymentsForRepurchaseOfPrivatePlacement_c20260420__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5TBGQ8WMXXe" title="Private placement offering">23,000 (after $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--PaymentsForCommissions_c20260420__20260508_z7ztME09NWw1" title="Broker commission">2,000 cash commission) and issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260420__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zP6MooRgLaY9" title="Number of shares issued">450,000 shares of Common Stock (after <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_ecustom--BonusShares_c20260420__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUiHdY7uq0E5" title="Bonus shares">33,333 bonus shares), as well as <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260420__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvjYv2bn98Sc" title="Warrants">416,667 <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260420__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRMvugLOtyxl" title="Weighted average remaining contractual term">5-year warrants exercisable to buy Common Stock at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iI_pid_c20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z1MFjPAO9HGg" title="Weighted average exercise price">0.12 per share. The net received by the Company was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20260508__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbKcAjPyqkNi" title="Shares issued, price per share">0.053 per unit. As at August 14, 2026, shares and warrants have not yet been issued.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">† </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">The shares will be issued as shares of Preferred Stock, but are for comparison purposes expressed as Common share equivalents.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">b</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to Rule 701 of the Securities Act.</td></tr> </table> Management sees no further subsequent events requiring disclosure.

23000

2000

0.051

0.020

<p id="xdx_89E_ecustom--ScheduleOfAllocationOfFairValueInPrivatePlacementTableTextBlock_hus-gaap--AwardTypeAxis__custom--UnitOfferingMember_zlKhglbG7vAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The allocation was calculated as follows: SCHEDULE OF ALLOCATION OF FAIR VALUE IN PRIVATE PLACEMENT <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Component</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Standalone Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Total Fair Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Allocation of Proceeds</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Allocation per Share/Warrant</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Common Stock (450,000 shares)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--FairValueOfCommonStock_iI_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqVwVXHWbQSb" style="text-align: right" title="Fair value of common stock">12,199</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--FairValueOfCommonStockPercenatge_iI_pid_dp_uPure_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7UPJgxqJCLh" title="% of Total Fair Value, Common stock">64.14</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8ZOTwIvtTdd" style="text-align: right" title="Allocation of Proceeds Common Stock">14,753</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMlmrwtV1M83" title="Share price">0.0328</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Common Stock (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFMTE9DQVRJT04gT0YgRkFJUiBWQUxVRSBJTiBQUklWQVRFIFBMQUNFTUVOVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z74gBUDTmzni" title="Number of shares issued">450,000 shares)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--FairValueOfCommonStock_iI_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zLf4Yj50qfd8" style="width: 12%; text-align: right" title="Fair value of common stock">12,199</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--FairValueOfCommonStockPercenatge_iI_pid_dp_uPure_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8rbB623ryba" title="% of Total Fair Value, Common stock">64.14</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zsWID7n0xKpi" style="width: 12%; text-align: right" title="Allocation of Proceeds Common Stock">14,753</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9P7OSWWNxw9" title="Share price">0.0328</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFMTE9DQVRJT04gT0YgRkFJUiBWQUxVRSBJTiBQUklWQVRFIFBMQUNFTUVOVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQE5xfDrkn1k" title="Number of shares issued">416,667 warrants)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--FairValueOfWarrants_iI_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvH64sUkzR51" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value of warrants">6,819</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--FairValueOfWarrantsPercenatge_iI_pid_dp_uPure_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwFUjsIKnhh2" title="% of Total Fair Value, Warrants">35.86</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ProceedsFromIssuanceOfWarrants_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZEFTEn2OGCi" style="border-bottom: Black 1pt solid; text-align: right" title="Allocation of Proceeds Warrants">8,247</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zf048DnXM0Ri" title="Allocation per Share/Warrant">0.0198</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Total</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--StandaloneFairValue_iI_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3ZQI97sU0t3" style="text-align: right" title="Standalone fair value">19,017</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span id="xdx_909_ecustom--PercenatgeOfTotalFairValue_iI_pid_dp_uPure_c20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zFlCpmQivIm" title="% of Total Fair Value">100</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--ProceedsFromOtherEquity_c20260701__20260701__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyCsnW3yIDb1" style="font-weight: bold; text-align: right" title="Allocation of Proceeds">23,000</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> 12199 0.6414

14753

0.0328

450000

12199 0.6414

14753

0.0328

416667

6819 0.3586

8247

0.0198

19017 1

23000

The allocated value per share is $0.033 ($14,753 ÷ 450,000 shares), and the allocated value per warrant is $0.020 ($8,247 ÷ 416,667 warrants), or a 20.9% premium to market.

<p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_zHQoOh2hm9Be" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Shares earned/paid, but not yet issued, subsequent to June 30, 2026: SCHEDULE OF SHARES AWARDED <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"># Shares</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Price/Share</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">7/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center">b</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">† </td> <td style="width: 1%"> </td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021Member__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYiCG_zZPybTI2KEnd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares">31,081,875</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021Member__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYiCG_zmimaGWxuS94" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Amount">1,360,606</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98B_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021Member__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYiCG_zjr0VvFoO1Tg" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Price/Share">0.044</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%">plan 2021</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center">affiliate</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">7/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">b</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021OneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYg_____zKuOA6LKYTje" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">705,058</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021OneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYg_____zFWehNhtdAh2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">30,619</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_983_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--Plan2021OneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYg_____zLP4722EKggb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.043</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">plan 2021</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">7/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____z26n0lwTcece" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">736,770</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____za1PwnkRKKLk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">27,476</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_984_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zL4HRbi9U7ad" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.037</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fee</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">7/01/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--CommissionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zF2fpQ0RhQ1f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">106,667</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260701__20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--CommissionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____znCSqOlUZ60e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--SharePrice_iI_pid_c20260701__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--CommissionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____z78wXCsrnLE1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">commission</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">7/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">*</td> <td> </td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260708__20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_z6UUTqozyLO8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">450,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260708__20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zzHsBuiT0eml" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">14,753</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98C_eus-gaap--SharePrice_iI_pid_c20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zJDBiQzoVYqg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.033</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">private placement</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">7/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif">*</td> <td> </td> <td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260708__20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PrivatePlacementOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zMNWOWWfMXz1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_981_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260708__20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PrivatePlacementOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zXYoiNmdeWOb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">8,247</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--SharePrice_iI_pid_c20260708__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--PrivatePlacementOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zg0rDU08mDe7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">—</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">private placement</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">7/05/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260705__20260705__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zGcA7HpZtS2b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">150,000</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_989_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260705__20260705__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zzl7QsJDKaHh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">3,750</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_986_eus-gaap--SharePrice_iI_pid_c20260705__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____z4N46wiJ5abd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.025</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">consulting fee</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt">8/10/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260810__20260810__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeTwoMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zdFlAxh2Nyb3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">150,000</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260810__20260810__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeTwoMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zqsktgjCeAO1" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">3,300</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_eus-gaap--SharePrice_iI_pid_c20260810__us-gaap--DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis__custom--ConsultingFeeTwoMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYQ_____zBgy87f01Sy2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.022</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">consulting fee</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">8/14/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260814__20260814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvD3OmbSMPHg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares">33,380,370</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260814__20260814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgsSbna3zXrb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount">1,448,751</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_989_eus-gaap--SharePrice_iI_pid_c20260814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zroutlTCrGU2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Price/Share">0.043</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> Warrants paid, but not yet issued, subsequent to June 30, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"># Warrants</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">wavg Term</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">wavg Exerc</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Type</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Notice</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%">7/08/2026</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">*</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: right"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_c20260708__20260708__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zzRk6ZXkb3Y4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Warrants Outstanding, Number of Warrants">416,667</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260708__20260708__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zZwu740f5YIb" title="Weighted average remaining contractual term, Ending balance">5.0</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iI_c20260708__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_fYSAq_zUUuwlE5cWC1" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price">0.12</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td id="xdx_F08_zeqpqhBMIZI1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: center">*</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">During the period from April 20, 2026, to May 8, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zjdYbdCvuX0k" title="Market price">0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_ecustom--CashCommissionPercentage_pid_dp_c20260420__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zEiQp0QDFum8" title="Cash commission percentage">8% cash commission and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_ecustom--BonusSharesPercentage_pid_dp_c20260420__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5zJ7Is1owj5" title="Bonus shares percentage">8% bonus shares. The Company raised a total of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--PaymentsForRepurchaseOfPrivatePlacement_c20260420__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5TBGQ8WMXXe" title="Private placement offering">23,000 (after $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--PaymentsForCommissions_c20260420__20260508_z7ztME09NWw1" title="Broker commission">2,000 cash commission) and issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260420__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zP6MooRgLaY9" title="Number of shares issued">450,000 shares of Common Stock (after <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_ecustom--BonusShares_c20260420__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUiHdY7uq0E5" title="Bonus shares">33,333 bonus shares), as well as <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20260420__20260508__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvjYv2bn98Sc" title="Warrants">416,667 <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2End_dtY_c20260420__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRMvugLOtyxl" title="Weighted average remaining contractual term">5-year warrants exercisable to buy Common Stock at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice_iI_pid_c20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z1MFjPAO9HGg" title="Weighted average exercise price">0.12 per share. The net received by the Company was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFUyBBV0FSREVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20260508__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbKcAjPyqkNi" title="Shares issued, price per share">0.053 per unit. As at August 14, 2026, shares and warrants have not yet been issued.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">† </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">The shares will be issued as shares of Preferred Stock, but are for comparison purposes expressed as Common share equivalents.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">a</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">b</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to Rule 701 of the Securities Act.</td></tr> </table>

31081875

1360606

0.044

705058

30619

0.043

736770

27476

0.037

106667

450000

14753

0.033

8247

150000

3750

0.025

150000

3300

0.022

33380370

1448751

0.043

416667

P5Y 0.12

0.06

0.08 0.08

23000

2000

450000

33333

416667

P5Y 0.12

0.053

The transaction originating from the Company’s Officers forfeiting payroll of $941,890, whereof $214,780 was accrued in prior year. (See note 7 for more details) To the CFO and CEO, there was $843,615 and $427,000 in accrued payroll as of June 30, 2026 and December 31, 2025, respectively. As of June 30, 2026, and at December 31, 2025, the Company had recorded reserves for contingent compensation claims of $157,500 and $11,000 relating to disputed compensation and expense reimbursement claims asserted by the former Chief Commercial Officer and current shareholder. These amounts reflect management’s reserve associated with a disputed matter and do not represent routine accrued payroll obligations incurred in the ordinary course. As of June 30, 2026, the amount to be converted into shares of Preferred Stock is $1,360,606. This consist of $82,006 is to our Directors for their attendance at board and committee meetings during the fourth quarter and $1,278,600 to Dr. Platt as a performance grant in recognition of his role in executing the Company’s first commercial distribution agreement and advancing capital funding initiatives. On December 31, 2025 this amount was $82,006. On June 30, 2026, the Company has a $355,598 loan from an affiliated company with an interest rate of 8%. The accrued interest is currently $75,761. On December 31, 2025, the Company the loan was $395,668 and the accrued interest $52,459. The note was sold on May 3, 2021 with a face value of $1,000,000 and debt discount of $102,875 paid to the sole Placement Agent: WallachBeth Capital, LLC (Member FINRA / SIPC). The number of months used in the calculation to estimate the value of the derivative debt. The transaction originating from the Company’s Officers forfeiting $578,959 of accrued payroll in the first quarter of 2025. Around January 23, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised a total of $241,040 (after $20,960 cash commission) and issued 4,716,000 shares of Common Stock (after 349,333 bonus shares), as well as 4,366,6675-year warrants exercisable to buy Common Stock at $0.12 per share. The net received by the Company was $0.053 per unit. The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act. Around May 8, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised a total of $73,600 (after $6,400 cash commission) and issued 1,440,001 shares of Common Stock (after 106,667 bonus shares), as well as 1,333,3345-year warrants exercisable to buy Common Stock at $0.12 per share. The net received by the Company was $0.053 per unit. The Company claims an exemption from the registration requirements of the Securities Act pursuant to the exchange exemption under Rule 144 of the Securities Act. The Company claims an exemption from the registration requirements of the Securities Act pursuant to the exchange exemption in Rule 3(a)(9) of the Securities Act. The Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to Rule 701 of the Securities Act. The shares will be issued as shares of Preferred Stock, but are for comparison purposes expressed as Common share equivalents in this table. The Board of Directors awarded the CEO 6,000,000 Preferred Shares, a 1:5 conversion, as a performance grant in recognition for his role in advancing capital funding initiatives and establishing a distribution agreement for dietary supplements. During the period from April 20, 2026, to May 8, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised a total of $23,000 (after $2,000 cash commission) and issued 450,000 shares of Common Stock (after 33,333 bonus shares), as well as 416,6675-year warrants exercisable to buy Common Stock at $0.12 per share. The net received by the Company was $0.053 per unit. As at August 14, 2026, shares and warrants have not yet been issued. The Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act. The shares will be issued as shares of Preferred Stock, but are for comparison purposes expressed as Common share equivalents. The Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to Rule 701 of the Securities Act.